The present disclosure relates generally to systems, apparatus, and methods for collecting and transporting urine away from the body of a person or animal.
The embodiments described herein relate generally to collecting and transporting urine away from the body of a person or animal. In various circumstances, a person or animal may have limited or impaired mobility such that typical urination processes are challenging or impossible. For example, a person may experience or have a disability that impairs mobility. A person may have restricted travel conditions such as those experienced by pilots, drivers, and workers in hazardous areas. Additionally, sometimes urine collection is needed for monitoring purposes or clinical testing.
Urinary catheters, such as a Foley catheter, can be used to address some of these circumstances, such as incontinence. Unfortunately, however, urinary catheters can be uncomfortable, painful, and can lead to complications, such as infections. Additionally, bed pans, which are receptacles used for the toileting of bedridden patients, such as those in a health care facility, are sometimes used. Bed pans, however, can be prone to discomfort, spills, and other hygiene issues.
Males who suffer the most severe consequences of urinary incontinence, such as discomfort, rashes, and sores are typically elderly and often bedbound. They also require continuous assistance to maintain hygiene. Characteristics often found in these patients: they typically lay on their back, the size of the penis often decreases with age, skin rolls containing fat tissue cause the penis to recede, often pointing upward while in a laying position, patients have difficulty reaching the penis and manipulating devices. A urine capture device should be designed with reference to these characteristics.
Available solutions are typically for use while standing up (such as cups and funnels), with a urine discharge port opposite to the distal end of the penis. Other designs such as condom-style catheters are difficult for patients to manipulate, too often they are dimensionally incompatible; and they do not stay on reliably.
Thus, there is a need for a device capable of collecting urine from a person or animal, particularly a male, comfortably and with minimal contamination of the user and/or the surrounding area.
A system is disclosed that is suitable for collecting and transporting urine away from the body of a person or animal, particularly a male. The disclosed system includes an assembly that may include a fluid impermeable casing, a fluid permeable support, a fluid permeable membrane, and a tube. The fluid impermeable casing can define an opening, an interior region, and a fluid outlet. The fluid permeable support can define a reservoir. The support can be disposed within the interior region. The fluid permeable membrane can be disposed on the support and cover at least a portion of the support. The fluid permeable membrane can at least partially define a cavity. The tube can have a first end disposed in the elongated reservoir and can extend through the fluid outlet to a second, fluid discharge end. The apparatus is configured to be disposed with a user's penis disposed through the opening and with the urethral opening of the penis disposed within the cavity, to receive urine discharged from the urethral opening through the membrane, the support, and into the reservoir, and to have the received urine withdrawn from the reservoir via the tube and out of the fluid discharge end of the tube.
A system is disclosed that is suitable for collecting and transporting urine away from the body of a person or animal, particularly a male. In some embodiments, the disclosed system includes an apparatus that may include a fluid impermeable casing, a fluid permeable support, a fluid permeable membrane, and a tube. The fluid impermeable casing can define an opening, an interior region, and a fluid outlet. The fluid permeable support can define a reservoir. The support can be disposed within the interior region. The fluid permeable membrane can be disposed on the support and cover at least a portion of the support. The fluid permeable membrane can at least partially define a cavity. The tube can have a first end disposed in the elongated reservoir and can extend through the fluid outlet to a second, fluid discharge end. The apparatus is configured to be disposed with a user's penis disposed through the opening and with the urethral opening of the penis disposed within the cavity, to receive urine discharged from the urethral opening through the membrane, the support, and into the reservoir, and to have the received urine withdrawn from the reservoir via the tube and out of the fluid discharge end of the tube.
In some embodiments, a method includes disposing in operative relationship with the urethral opening of a male user, a urine collecting apparatus. The method can include disposing in operative relationship with the urethral opening of a male user a urine collecting apparatus. The urine collecting apparatus can include a fluid impermeable casing, a fluid permeable support, a fluid permeable membrane, and a tube. The fluid impermeable casing can define an opening, an interior region, and a fluid outlet. The fluid permeable support can define a reservoir. The support can be disposed within the interior region. The fluid permeable membrane can be disposed on the support and can cover at least the portion of the support. The fluid permeable membrane can at least partially define a cavity. The tube can have a first end disposed in the elongated reservoir and extending through the fluid outlet to a second, fluid discharge end. The operative relationship can include the user's penis being disposed through the opening in the casing with the urethral opening of the penis disposed within the cavity. Urine discharged from the urethral opening can be allowed to be received through the membrane, the support, and into the reservoir. The received urine can be withdrawn from the reservoir via the tube and out of the fluid discharge end of the tube.
In some embodiments, an apparatus can include a fluid impermeable casing, a fluid permeable support, a fluid permeable membrane, and a tube. The fluid impermeable casing can define an opening, an interior region, and a fluid outlet. The fluid permeable support can be disposed within the interior region and have a first side facing the opening and a second side opposite the first side. The second side and the casing can collectively define a reservoir between the second side and the casing. The fluid permeable membrane can be disposed on the support between the opening and the first side of the support. The fluid permeable membrane and the casing can collectively define a cavity. The tube can have a first end disposed in the reservoir and can extend through the fluid outlet to a second, fluid discharge end. The apparatus can be configured to be disposed with a user's penis disposed through the opening with the urethral opening of the penis disposed within the cavity, to receive urine discharged from the urethral opening through the membrane, the support, and into the reservoir, and to have the received urine withdrawn from the reservoir via the tube and out of the fluid discharge end of the tube.
In some embodiments, a method can include disposing in operative relationship with the urethral opening of a male user a urine collecting apparatus. The urine collecting apparatus can include a fluid impermeable casing, a fluid permeable support, a fluid permeable membrane, and a tube. The fluid impermeable casing can define an opening, an interior region, and a fluid outlet. The fluid permeable support can be disposed within the interior region and have a first side facing the opening and a second side opposite the first side. The second side and the casing can collectively defining a reservoir between the second side and the casing. The fluid permeable membrane can be disposed on the support between the opening and the first side of the support. The fluid permeable membrane and the casing can collectively defining a cavity. The tube can have a first end disposed in the reservoir and can extend through the fluid outlet to a second, fluid discharge end. The operative relationship can include the user's penis being disposed through the opening in the casing with the urethral opening of the penis disposed within the cavity. Urine discharged from the urethral opening can be allowed to be received through the membrane, the support, and into the reservoir. The received urine can be allowed to be withdrawn from the reservoir via the tube and out of the fluid discharge end of the tube.
In some embodiments, a device can be used to so collect urine flowing from the penis of a person or an animal in such a manner that the urine can be readily transported from the device as the urine is being collected. The device can include a chamber assembly in which wicking material is disposed about porous material that is configured to form a chamber in which urine can be collected for transport. The chamber can have a port for receiving a tube so that urine collected within the chamber can be transported from the chamber by being drawn from the chamber when a partial vacuum is applied within the chamber via said received tube. The chamber assembly can be so dimensioned and configured that opposing portions of the assembly can be sufficiently adjacent as to define an opening through the which the head of a penis can be inserted. A layer of impermeable material can be so attached to the chamber assembly as to cover one side of the opening and thereby provide a receptacle for receiving the head of said inserted penis. Urine flowing from said penis can be drawn from the receptacle through the wicking material and the porous material into the chamber when said partial vacuum is applied within the chamber via said tube.
In some embodiments, a device can be used to so collect urine flowing from the penis of a person or an animal in such a manner that the urine can be transported from the device as the urine is being collected. The device can include a flexible layer of porous material, a flexible wicking material disposed on one side of the layer of porous material, and a flexible layer of impermeable material. The flexible layer of impermeable material can be secured to the periphery of the other side of the layer of porous material and so cover the other side of the layer of porous material as to define a chamber between the layer of porous material and the layer of impermeable material, within which chamber urine can be collected for transport. The chamber can have a port for receiving a tube so that urine collected within the chamber can be transported from the chamber by being drawn from the chamber when a partial vacuum is applied within the chamber via said received tube. The combination of the wicking material, the layer of porous material, and the layer of impermeable material can be so dimensioned and configured as to provide a receptacle for receiving the head of a penis. Urine flowing from said penis can be drawn from the receptacle through the wicking material and the porous material into the chamber when said partial vacuum is applied within the chamber via said received tube.
As used in this specification, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Thus, for example, the term “a member” is intended to mean a single member or a combination of members, “a material” is intended to mean one or more materials, or a combination thereof.
The embodiments described herein can be formed or constructed of one or more biocompatible materials. Examples of suitable biocompatible materials include metals, ceramics, or polymers. Examples of suitable metals include pharmaceutical grade stainless steel, gold, titanium, nickel, iron, platinum, tin, chromium, copper, and/or alloys thereof. Examples of polymers include nylons, polyesters, polycarbonates, polyacrylates, polymers of ethylene-vinyl acetates and other acyl substituted cellulose acetates, non-degradable polyurethanes, polystyrenes, polyvinyl chloride, polyvinyl fluoride, poly(vinyl imidazole), chlorosulphonate polyolefins, polyethylene oxide, polyethylene terephthalate (PET), polytetrafluoroethylene (PTFE), and/or blends and copolymers thereof.
More specifically, the impermeable casing 150 can define an interior region accessible via the opening 132. The permeable membrane 130 and the permeable support 140 (and thus, the reservoir 110) can be disposed within the interior region of the impermeable casing 150. The impermeable casing 150 can be any suitable shape. For example, in some implementations, the impermeable casing 150 can be bowl-shaped. In some implementations, the impermeable casing 150 can include a bottom surface and at least one sidewall. In some implementations, the at least one sidewall can define the opening 132 such that the opening 132 is opposite the bottom surface of the impermeable casing 150 and the interior region of the impermeable casing 150 is bounded (and collectively defined) by the bottom surface, the sidewall, and the opening 132. In some implementations, the impermeable casing 150 includes a top surface and the top surface defines the opening 132 opposite the bottom surface. In some implementations, the sidewall of the impermeable casing 150 is curved and continuous such that the impermeable casing 150 has a round (e.g., circular or ovalular) perimeter. In some implementations, the impermeable casing 150 can have any suitable shape and/or perimeter, such as the shape of an oblong, a square, or a triangle. In some implementations, the one or more sidewalls can be concave such that the one or more sidewalls can receive at least a portion of the permeable membrane 130 and the permeable support 140 as described in more detail below.
In some implementations, the impermeable casing 150 can be disposed around only a portion of the exterior sides of the permeable membrane 130 and/or the permeable support 140. In some implementations, the impermeable casing 150 can cover all of the exterior sides of the chamber assembly (i.e., the permeable membrane 130 and/or permeable support 140). In some implementations, the impermeable casing 150 can be disposed such that the impermeable casing 150 can wrap around the exterior surface of the permeable membrane 130 and/or the permeable support 140 and cover a portion of the interior side or sides of the chamber assembly (i.e., the permeable membrane 130 and/or the permeable support 140). In some implementations, the permeable membrane 130 and the permeable support 140 can be arranged to define a passageway with open ends (e.g., as a ring), and the impermeable casing 150 can be applied to one end and a side of the chamber assembly (i.e., the permeable membrane 130 and the permeable support 140) such that a cavity 152 is defined with the open end and the closed end. In some implementations, the chamber assembly can define the opening 132 rather than the impermeable casing 150. In some implementations, the portion of the impermeable casing 150 closing one end of the cavity 152 and partially defining the cavity 152 can have any suitable shape such that a portion or all of the head of a user's penis can be disposed within the cavity 152. For example, the portion of the impermeable casing 150 closing one end of the cavity 152 can be curved, convex, or flat.
In some implementations, the impermeable casing 150 can be attached to the chamber assembly (i.e., the permeable membrane 130 and the permeable support 140) via an adhesive. In some implementations, the impermeable casing 150 can be attached to the chamber assembly via any suitable retention mechanism, such as, for example, retainer clips or other fasteners. In some implementations, the impermeable casing 150 can be preshaped and the chamber assembly can be inserted into the impermeable casing 150 and retained in a particular shape by the impermeable casing 150. In some implementations, the impermeable casing 150 can be formed by, for example, elongate strips of adhesive tape such that the impermeable casing 150 can maintain the chamber assembly in the configuration defining the cavity 152.
The impermeable layer 150 can be impermeable to fluid, such as, for example, urine. In some implementations, the impermeable layer 150 can have a fluid transportation function and can assist in directing fluid towards the reservoir 110 and/or through the outlet 120 of the reservoir 110. In some implementations, the impermeable layer 150 can be formed as an integral, unitary structure. In other implementations, the impermeable layer 150 can be a multi-piece structure. The impermeable layer 150 can be a pre-molded (e.g., injection or blow molded) component. Alternatively, the impermeable layer 150 can be formed of a material, such as elongate strips of an adhesive tape, wrapped around at least a portion of the reservoir 110, a portion of the permeable support 140, and/or a portion of the permeable membrane 130. In some embodiments, the impermeable layer 150 can be formed of cardboard, pressed paper, and/or coated paper. In some embodiments, the impermeable layer 150 can be flexible.
The permeable membrane 130 can be formed of a material that has permeable properties with respect to liquids such as urine. The permeable properties can be wicking, capillary action, diffusion, or other similar properties or processes, and are referred to herein as “permeable” and/or “wicking.” The permeable membrane 130 can have a high absorptive rate and a high permeation rate such that urine can be rapidly absorbed by the permeable membrane 130 and/or transported through the permeable membrane 130. In some implementations, the permeable membrane 130 can be flexible. In some implementations, the permeable membrane 130 can be a ribbed knit fabric. In some implementations, the permeable membrane 130 can be shaped as a tubular sleeve such that the permeable membrane 130 can be disposed around the permeable support 140. In some implementations, the permeable membrane 130 can include and/or have the moisture-wicking characteristic of gauze, felt, terrycloth, thick tissue paper, and/or a paper towel. In some implementations, the permeable membrane 130 can be soft and/or minimally abrasive such that the permeable membrane 130 does not irritate the skin of the user. The permeable membrane 130 can be configured to wick fluid away from the urethral opening and/or the skin of the user such that the dampness of the skin of the user is lessened and infections are prevented. Additionally, the wicking properties of the permeable membrane 130 can help prevent urine from leaking or flowing beyond the assembly (e.g., out of opening 132) onto, for example, a bed. In some implementations, the permeable membrane 130 can be formed of fine denier polyester fibers coated with a thermoplastic water-based binder system. The tensile strength can be, for example, about 45 lbs/inch2 (measured using an Instron test method). The weight of a permeable membrane can be, for example, about 12 grams (measured using the Mettler Gram Scale). The thickness per ten permeable membranes can be, for example, about 2.5″ (measured using the Gustin-Bacon/Measure-Matic).
The permeable support 140 can be positioned relative to the permeable membrane 130 such that the permeable support 140 maintains the permeable membrane 130 in a particular shape and allows for fluid, such as, for example, urine, to flow through the permeable membrane 130, through the permeable support 140, and into the reservoir 110. In some implementations, the permeable support 140 can be ring-shaped such that, when disposed within the impermeable casing 150, the cavity 152 is defined in the center of the ring-shaped permeable support 140. Said another way, an outer surface of the permeable support 140 on the inner portion of the “ring” can define the cavity 152. When the permeable membrane 130 is disposed on the permeable support 140, the permeable membrane 130 can define a portion of the boundaries of the cavity 152. When the permeable support 140 and the permeable membrane 130 are disposed within the impermeable casing 150, the cavity 152 can be aligned with the opening 132 of the impermeable casing 150. The reservoir 110 can be defined within or by the permeable support 140 such that the reservoir 110 is an elongated, ring-shaped reservoir.
In some implementations, the permeable support 140 can be shaped and/or formed as a complete or continuous ring or circle. In some implementations, the permeable support 140 can be shaped and/or formed as a partial circle and/or in a discontinuous C-shape with spaced ends. In some implementations, the permeable support 140 can be U-shaped. In some implementations, the chamber assembly can be dimensioned and configured such that opposing end portions of the chamber assembly are sufficiently adjacent or proximate as to define an opening through which the head of a penis can be inserted. In some implementations, the permeable support 140 can be formed of a bendable tube having two ends. The bendable tube can be arranged such that the two ends meet (e.g., forming a C-shape) and the permeable support 140 can be secured such that the permeable support 140 has a substantially circular shape. In some implementations, the outlet or port 120 can be positioned at the intersection of the two ends and in fluid communication with the elongated ring-shaped reservoir 110 defined by the permeable support 140. The discharge line 122 can be inserted through the outlet 120 (and thus through the impermeable casing 150 and the permeable support 140) and into fluid communication with the reservoir 110.
In some implementations, the permeable support 140 can be formed as an elongated tube such that the reservoir 110 extends through a portion or through the entire length of the elongated tube. The permeable support 140 can then be arranged and/or bent to form a ring such that the permeable support 140 defines the cavity 152 in the center of the ring. In some implementations, the inner diameter or other dimensions of the permeable support 140 can be sized such that the cavity 152 can receive a penis of a user such that a head of the penis can be partially or fully disposed within the cavity 152 when the penis is disposed within the opening 132 of the impermeable casing 150. Said another way, the shaft of the penis can be disposed within the opening 132 and the head of the penis can be fully disposed within the cavity 152, or the urethral opening of the head of the penis can be disposed within the cavity 152 and the head can be partially disposed within the cavity 152 and partially outside the cavity 152, with the opening 132 surrounding a portion of the head. In some implementations, the cavity 152 can be dimensioned to receive a head of a penis of a user such that urine can be received from the urethral opening of the penis within the cavity 152, by the permeable membrane 130, and/or by the permeable support 140 without urine splashing out of the opening 132.
In some implementations, the permeable support 140 can be configured to maintain the permeable membrane 130 against the skin of a penis of a user and/or near a urethral opening of a user. For example, the permeable support 140 can be shaped and sized such that the cavity 152 is slightly larger than a head or tip of a penis of a user. The permeable support 140 can include a portion having a curved or convex shape in contact with the permeable membrane 130 such that the permeable membrane 130 is also curved or convex. The permeable support 140 can support the permeable membrane 130 such that the permeable membrane 130 can rest against the skin of the head or tip of the penis with the urethral opening directed toward a bottom surface of the impermeable casing 150, and thus creating a comfortable and at least partially enclosed interface for engagement with the area of the body (e.g., the head and/or neck of a penis of a user) near the urethral opening.
In some implementations, the permeable support 140 can be made of a rigid plastic. In some implementations, the permeable support 140 can have any suitable shape and be formed of any suitable material. For example, the permeable support 140 can be flexible. Additionally, the permeable support 140 can be formed of aluminum, a composite of plastic and aluminum, some other metal and/or a composite of plastic and another metal. In some implementations, the permeable support 140 can be formed of a natural material, such as, for example, plant fibers (e.g., Greener Clean manufactured by 3M®). The natural material can include openings that allow fluid to flow through the natural material. In some embodiments, the permeable support 140 can be cylindrical and can define a lumen. In some embodiments, the permeable support 140 can be formed of perforated coated paper, such as tubular waxed paper.
The permeable support 140 can define one or more openings (e.g., an array of openings) to allow for fluid flow from the permeable membrane 130 to the reservoir 110. In some implementations, the permeable support 140 can be formed as a curved tube or a curved cylinder with one or more openings. In some implementations, the permeable support 140 can include membrane supports (e.g., struts) extending across an opening such that the opening is divided into an array of distinct slot-shaped openings. The membrane supports can be used to support the permeable membrane 130. For example, the membrane supports can maintain the shape of the permeable membrane 130 against the skin of a penis of a user and/or near a urethral opening of a user such that urine flowing from the urethral opening contacts and travels through the permeable membrane 130. In some implementations, the permeable support 140 can define several openings having a variety of shapes, such as a plurality of round openings. In some implementations, the permeable support 140 can be formed as a curved or ring-shaped cylinder of spun plastic (e.g., non-woven permeable nylon and polyester webbing) such that the permeable support 140 can have many openings. For example, a rectangular portion of spun plastic can be folded or rolled into a cylinder shape and then curved into a ring or U-shape for use in the assembly 102. In some implementations, the permeable support 140 can be formed of a porous material. For example, the permeable support 140 can be a porous glass ring-shaped tubular container defining frits. In other implementations, the permeable support 140 can define an opening in a sidewall of the permeable support 140 and the sidewall can be covered by a mesh screen defining many smaller openings. In some embodiments, the reservoir 110 can include any spaces and/or openings defined within the permeable support 140 (e.g., spaces within porous material or defined within spun plastic material).
The reservoir 110 can be any suitable shape and/or have any diameter (or other dimension) suitable for receiving and transporting urine during use of the system 100. In some implementations, the reservoir 110 can be sized such that the reservoir 110 is capable of collecting and temporarily holding a large or small amount of urine until the urine can be removed from the reservoir via the outlet 120. For example, the reservoir 110 can be sized such that the reservoir 110 is configured to hold a small amount of urine as may be released due to incontinence. In some implementations, the reservoir 110 can be sized such that the reservoir 110 is configured to hold a large amount of urine as may be released during voiding of a full bladder. In some implementations, the reservoir 110 can be sized such that the reservoir is configured to collect and hold a small or large amount of urine while the urine is simultaneously removed via, for example, gravity and/or a pump, such as the vacuum source 170. Said another way, the reservoir 110 can function as a sump and be sized such that the reservoir 110 can form a portion of a passageway for urine from the permeable membrane 130, through the permeable support 140, through the reservoir 110, and out of the outlet 120. In a condition where the flow rate of urine into the assembly 102 via the permeable membrane 130 is greater than the flow rate of urine through the discharge line 122, a temporary backup of urine may occur in the reservoir 110. Thus, the reservoir 110 can be sized to contain a volume of fluid that may temporarily accumulate due to the difference in flow rates into and out of the assembly 102. Although the outlet 120 is shown as extending from the side of the reservoir 110, in some implementations, the outlet 120 can extend from the bottom of the reservoir 110.
In some embodiments, the assembly 102 can optionally include a cushion assembly 180. The cushion assembly 180 can include a membrane layer 182 and a support layer 184 (also referred to herein as a “bed of porous material”). The membrane layer 182 can be formed of the same or a similar material as the permeable membrane 130 and can have the same or similar properties as the permeable membrane 130. For example, the membrane layer 182 can be configured to wick fluid (e.g., urine) away from a urethral opening of a user when a urethral opening of a user is position near or in contact with the membrane layer 182. The membrane layer 182 can also be permeable such that fluid (e.g., urine) can flow through the membrane layer 182 and to the permeable membrane 130 and/or the permeable support 140, into the reservoir 110, and through the outlet 120. The support layer 184 can be formed of the same or a similar material as the permeable support 140 and can have the same or similar properties as the permeable support 140. For example, the support layer 184 can be configured to maintain the membrane layer 182 near or in contact with the head of a user's penis when the head of the user's penis is disposed within the cavity 152 of the assembly 102. The support layer 184 can also be permeable such that fluid (e.g., urine) can flow through the membrane layer 182, through the support layer 184, and to the permeable membrane 130 and/or the permeable support 140, into the reservoir 110, and through the outlet 120. The cushion assembly 180 can be arranged within the impermeable casing 150 such that the cushion assembly 180 forms a boundary of the cavity 152 (e.g., the bottom of the cavity 152). The cushion assembly 180 can be positioned along a bottom surface of the impermeable casing 150 such that a user's penis can be placed in contact with the cushion assembly 180 and/or such that urine flowing from a user's urethral opening into the cavity 152 can flow into the cushion assembly 180 thereby reducing splashing. In some implementations, the cushion assembly 180 (and specifically the membrane layer 182) can be disposed within the impermeable casing 150 such that the cushion assembly 180 contacts the permeable membrane 130.
The external receptacle 160, via the discharge line 122, can collect fluid exiting the reservoir 110 through the outlet 120. The external receptacle 160 can be a sealed container. In some implementations, the external receptacle 160 can be disposable. In some implementations, the external receptacle 160 can be configured to be sterilized and reused.
In some implementations, gravity can cause fluid within the reservoir 110 to follow a flow path (i.e., the fluid flow path including the outlet 120 and the discharge line 122) from the reservoir 110 to the external receptacle 160. In some implementations, the vacuum source 170 can assist and/or provide the pressure differential needed to draw fluid voided from the urethral opening of a user into the permeable support 140, into the reservoir 110, and from the reservoir 110 into the external receptacle 160. The vacuum source 170 can be fluidically coupled to the external receptacle 160 via a vacuum line 124 such that gaseous fluid is drawn from the external receptacle 160 via the vacuum line 124. As a result of the decrease in pressure within the external receptacle 160 caused by the drawing of gaseous fluid out of the external receptacle 160, liquid and/or gaseous fluid can be drawn from the reservoir 110, through the outlet 120, through the discharge line 122, and into the external receptacle 160. In some implementations, the vacuum source 170 can apply sufficient suction to capture all or substantially all of the urine voided by a user in a variety of positions (e.g., when a male user is lying on his side or back).
The vacuum source 170 can have a sufficiently high vacuum strength and air volume transport rate such that rapid air and liquid aspiration is maintained over a portion of or the entire permeable membrane 130. In some implementations, the one or more openings of the permeable support 140 are distributed over an area that is slightly larger than the area of the permeable membrane 130 that is configured to be wetted by urine flow in operation. Thus, the partial vacuum created by the vacuum source 170 in combination with the one or more openings of the permeable support 140 and the permeable membrane 130 can draw the urine contacting the permeable membrane 130 into the assembly 102 and, specifically, into the reservoir 110. In some implementations, however, the one or more openings of the permeable support 140 should not be distributed over too large of an area of the permeable support 140 because the partial vacuum strength may be reduced, thereby reducing the urine collection rate and the efficiency of the system 100.
In some implementations, the vacuum source 170 can be a pump that is readily available, inexpensive, relatively quiet, and/or configured to run continuously. For example, the vacuum source 170 can be an aquarium aerator pump. The vacuum line 124 can be attached to the intake port of the aquarium aerator pump (rather than the exhaust port of the aerator) such that gaseous fluid is drawn into the aquarium aerator pump from the external receptacle 160 via the vacuum line 124. In some implementations, the necessary static vacuum of the system 100 is about 3-10 feet of water (10%-30% of one atmosphere; 80-250 mm Hg) with a free-flow rate of about 10-100 cubic centimeters per second. In some implementations, the necessary static vacuum of the system 100 is higher or lower depending on the size of the user and the expected rate of urine flow from the user and/or through the system 100. In some implementations, the discharge line 122 can be about 0.25″ in diameter and the vacuum source 170 can be configured to cause about 500 cubic centimeters of urine to flow through the discharge line 122 to the external receptacle 160 over the duration of a typical urination event for a user, which may typically range from 10 to 20 seconds but may be shorter or longer, e.g., 5 to 90 seconds. In some implementations, the vacuum source 170 can include a wall-mounted vacuum system, such as is found in hospitals. In some implementations, a wall-mounted vacuum system can be configured to apply a vacuum of, for example, about 20 mm Hg to about 40 mm Hg. In some implementations, the vacuum source 170 can be powered by electrical AC or DC power. For example, in mobile applications when the user is away from an AC power source, such as when the user is using the system 100 during transportation via a wheel chair or motor vehicle, the vacuum source 170 can be powered by DC power.
In some implementations, urine collected by any of the systems and/or assemblies described herein can be sampled for analysis using urine strips. Urine test strips can be used to test a variety of health measures. Urine test strips can be configured to change color in response to being wetted with urine to indicate a particular measurement (i.e., the colors can correspond to known measurement scales). In some implementations, a urine test strip (not shown) can be inserted into the discharge line 122 such that urine flowing from the outlet 120 to the external receptacle 160 contacts the urine test strip. The discharge line 122 can be transparent such that data on the urine test strip can be read through a wall of the discharge line 122. In some implementations, the urine test strip can be disposed within the external receptacle 160 such that urine flowing into the external receptacle 160 contacts the urine test strip. The external receptacle 160 can be at least partially transparent such that the urine test strip can be read through a wall of the external receptacle 160.
In some implementations, a camera, such as a camera built into a portable communication device (e.g., a smartphone, an iPhone, or the like) can be used to read the data on the urine test strip. The camera can capture an image of the test strip and the image can be processed using, for example, a smartphone application. The data read from the urine test strip can be sent to a clinician for analysis and/or sent to a cloud-based address for physician access.
In some implementations, the system 100 can include a scale (not shown). For example, the scale can be disposed underneath the external receptacle 160 such that the scale is configured to measure the weight of fluid (e.g., urine) in the external receptacle 160. The data indicating the weight of the fluid that has been delivered to the external receptacle 160 via the discharge line 122 can be measured at different time intervals and processed to determine how much urine, for example, has been voided by a user of the system 100.
Although described as being intended for use by an adult male, in some implementations the system 100 can be used in adult, pediatric, male, female, and veterinary applications for animals of different species and sizes. In female applications, the assembly 102 can be placed between the legs or labia of the user and held snugly against the external urethra by the pressure of friction from the user's body, by the pressure of the legs or by such means as an undergarment, elastic strips, and/or adhesive tape. In male applications, the assembly 102 can be placed such that a penis of a user is disposed within the assembly 102 (e.g., within the cavity 152 formed within the assembly 102). A male user can use the assembly 102 in any suitable position, such as, for example, while lying on his back, lying on his side, sitting, or standing. In some implementations, the head of the penis of the male user can be placed in contact with the permeable membrane 130 and/or the membrane layer 182 during urination. In some implementations, the head of the penis of the male user can be disposed at least partially within the cavity 452, but not placed in contact with the permeable membrane 430 and/or the membrane layer 182 during urination.
The permeable support 240 and the permeable membrane 230 can be arranged such that the permeable support 240 and/or the permeable membrane 230 collectively define a cavity 252 within the permeable membrane 230. The impermeable casing 250 can direct fluid toward the reservoir 210 and/or reduce and/or prevent fluid from exiting the assembly 202 except via the outlet 220. In some implementations, the assembly 202 can be arranged such that a fluid can flow through the opening 232, into the cavity 252, through the permeable membrane 230, through the permeable support 240, into the reservoir 210, and out of the outlet 220. In some implementations, the assembly 202 can be arranged such that a user's penis can be inserted through the opening 232 such that the user's urethral opening is disposed within the cavity 252 and a fluid can flow from the user's urethral opening, into the cavity 252, through the permeable membrane 230, through the permeable support 240, into the reservoir 210, and out of the outlet 220. A discharge line 222 (e.g., a tube) (also referred to herein as a “received tube”) can extend through the outlet 220. A first end (not shown) of the discharge line 222 can be positioned within the reservoir 210, and the discharge line 222 can extend through the permeable support 240, the permeable membrane 230, and the impermeable casing 250 such that fluid in the reservoir 210 can be transported away from the assembly 202 via the discharge line 222. A second end of the discharge line 222 can be fluidically coupled to an external receptacle (e.g., external receptacle 160). The external receptacle can be in fluidic communication with a vacuum source (e.g., vacuum source 170) via a vacuum line (e.g., vacuum line 124). The discharge line 222 and the vacuum line can both include flexible tubing, such as, for example, flexible plastic tubing.
More specifically, the impermeable casing 250 can define an interior region accessible via the opening 232. The permeable membrane 230 and the permeable support 240 (and thus, the reservoir 210) can be disposed within the interior region of the impermeable casing 250. The impermeable casing 250 can be any suitable shape. For example, in some implementations, the impermeable casing 250 can be bowl-shaped. As shown in
The impermeable layer 250 can be impermeable to fluid, such as, for example, urine. In some implementations, the impermeable layer 250 can have a fluid transportation function and can assist in directing fluid towards the reservoir 210 and/or through the outlet 220 of the reservoir 210. In some implementations, the impermeable layer 250 can be formed as an integral, unitary structure. In other implementations, the impermeable layer 250 can be a multi-piece structure. The impermeable layer 250 can be a pre-molded (e.g., injection or blow molded) component. Alternatively, the impermeable layer 250 can be formed of a material, such as elongate strips of an adhesive tape, wrapped around at least a portion of the reservoir 210, a portion of the permeable support 240, and/or a portion of the permeable membrane 230. In some embodiments, the impermeable layer 250 can be formed of cardboard, pressed paper, and/or coated paper. In some embodiments, the impermeable layer 250 can be flexible.
The permeable membrane 230 can be formed of a material that has permeable properties with respect to liquids such as urine. The permeable properties can be wicking, capillary action, diffusion, or other similar properties or processes, and are referred to herein as “permeable” and/or “wicking.” The permeable membrane 230 can have a high absorptive rate and a high permeation rate such that urine can be rapidly absorbed by the permeable membrane 230 and/or transported through the permeable membrane 230. In some implementations, the permeable membrane 230 can be flexible. In some implementations, the permeable membrane 230 can be a ribbed knit fabric. In some implementations, the permeable membrane 230 can be shaped as a tubular sleeve such that the permeable membrane 230 can be disposed around the permeable support 240. In some implementations, the permeable membrane 230 can include and/or have the moisture-wicking characteristic of gauze, felt, terrycloth, thick tissue paper, and/or a paper towel. In some implementations, the permeable membrane 230 can be soft and/or minimally abrasive such that the permeable membrane 230 does not irritate the skin of the user. The permeable membrane 230 can be configured to wick fluid away from the urethral opening and/or the skin of the user such that the dampness of the skin of the user is lessened and infections are prevented. Additionally, the wicking properties of the permeable membrane 230 can help prevent urine from leaking or flowing beyond the assembly (e.g., out of opening 232) onto, for example, a bed. In some implementations, the permeable membrane 230 can be formed of fine denier polyester fibers coated with a thermoplastic water-based binder system. The tensile strength can be, for example, about 45 lbs/inch2 (measured using an Instron test method). The weight of a permeable membrane can be, for example, about 12 grams (measured using the Mettler Gram Scale). The thickness per ten permeable membranes can be, for example, about 2.5″ (measured using the Gustin-Bacon/Measure-Matic).
The permeable support 240 can be positioned relative to the permeable membrane 230 such that the permeable support 240 maintains the permeable membrane 230 in a particular shape and allows for fluid, such as, for example, urine, to flow through the permeable membrane 230, through the permeable support 240, and into the reservoir 210. As shown in
In some implementations, the permeable support 240 can be shaped and/or formed as a complete or continuous ring or circle. In some implementations, the permeable support 240 can be shaped and/or formed as a partial circle. In some implementations, the chamber assembly can be dimensioned and configured such that opposing end portions of the chamber assembly are sufficiently adjacent or proximate as to define an opening through which the head of a penis can be inserted. In some implementations, the permeable support 240 can be formed of a bendable tube having two ends. The bendable tube can be arranged such that the two ends meet (e.g., forming a C-shape) and the permeable support 240 can be secured such that the permeable support 240 has a substantially circular shape. In some implementations, the outlet or port 220 can be positioned at the intersection of the two ends and in fluid communication with the elongated ring-shaped reservoir 210 defined by the permeable support 240. The discharge line 222 can be inserted through the outlet 220 (and thus through the impermeable casing 250 and the permeable support 240) and into fluid communication with the reservoir 210.
In some implementations, the permeable support 240 can be formed as an elongated tube such that the reservoir 210 extends through a portion or through the entire length of the elongated tube. The permeable support 240 can then be arranged and/or bent to form a ring such that the permeable support 240 defines the cavity 252 in the center of the ring. In some implementations, the inner diameter or other dimensions of the permeable support 240 can be sized such that the cavity 252 can receive a penis of a user such that a head of the penis can be partially or fully disposed within the cavity when the penis is disposed within the opening 232 of the impermeable casing 250. Said another way, the shaft of the penis can be disposed within the opening 232 and the head of the penis can be fully disposed within the cavity 252, or the urethral opening of the head of the penis can be disposed within the cavity 252 and the head can be partially disposed within the cavity 252 and partially outside the cavity 252, with the opening 232 surrounding a portion of the head. In some implementations, the cavity 252 can be dimensioned to receive a head of a penis of a user such that urine can be received from the urethral opening of the penis within the cavity 252, by the permeable membrane 230, and/or by the permeable support 240 without urine splashing out of the opening 232.
In some implementations, the permeable support 240 can be configured to maintain the permeable membrane 230 against the skin of a penis of a user and/or near a urethral opening of a user. For example, the permeable support 240 can be shaped and sized such that the cavity 252 is slightly larger than a head or tip of a penis of a user. The permeable support 240 can include a portion having a curved or convex shape in contact with the permeable membrane 230 such that the permeable membrane 230 is also curved or convex. The permeable support 240 can support the permeable membrane 230 such that the permeable membrane 230 can rest against the skin of the head or tip of the penis with the urethral opening directed toward a bottom surface of the impermeable casing 250, and thus creating a comfortable and at least partially enclosed interface for engagement with the area of the body (e.g., the head and/or neck of a penis of a user) near the urethral opening.
In some implementations, the permeable support 240 can be made of a rigid plastic. In some implementations, the permeable support 240 can have any suitable shape and be formed of any suitable material. For example, the permeable support 240 can be flexible. Additionally, the permeable support 240 can be formed of aluminum, a composite of plastic and aluminum, some other metal and/or a composite of plastic and another metal. In some implementations, the permeable support 240 can be formed of a natural material, such as, for example, plant fibers (e.g., Greener Clean manufactured by 3M®). The natural material can include openings that allow fluid to flow through the natural material. In some embodiments, the permeable support 240 can be cylindrical and can define a lumen. In some embodiments, the permeable support 240 can be formed of perforated coated paper, such as tubular waxed paper.
The permeable support 240 can define one or more openings (e.g., an array of openings) to allow for fluid flow from the permeable membrane 230 to the reservoir 210. In some implementations, the permeable support 240 can be formed as a curved tube or a curved cylinder with one or more openings. In some implementations, the permeable support 240 can include membrane supports (e.g., struts) extending across an opening such that the opening is divided into an array of distinct slot-shaped openings. The membrane supports can be used to support the permeable membrane 230. For example, the membrane supports can maintain the shape of the permeable membrane 230 against the skin of a penis of a user and/or near a urethral opening of a user such that urine flowing from the urethral opening contacts and travels through the permeable membrane 230. In some implementations, the permeable support 240 can define several openings having a variety of shapes, such as a plurality of round openings. In some implementations, the permeable support 240 can be formed as a curved or ring-shaped cylinder of spun plastic (e.g., non-woven permeable nylon and polyester webbing) such that the permeable support 240 can have many openings. For example, a rectangular portion of spun plastic can be folded or rolled into a cylinder shape and then curved into a ring for use in the assembly 202. In some implementations, the permeable support 240 can be formed of a porous material. For example, the permeable support 240 can be a porous glass ring-shaped tubular container defining frits. In other implementations, the permeable support 240 can define an opening in a sidewall of the permeable support 240 and the sidewall can be covered by a mesh screen defining many smaller openings. In some embodiments, the reservoir 210 can include any spaces and/or openings defined within the permeable support 240 (e.g., spaces within porous material or defined within spun plastic material).
The reservoir 210 can be any suitable shape and/or have any diameter (or other dimension) suitable for receiving and transporting urine during use of a system including the assembly 202. In some implementations, the reservoir 210 can be sized such that the reservoir 210 is capable of collecting and temporarily holding a large or small amount of urine until the urine can be removed from the reservoir via the outlet 220. For example, the reservoir 210 can be sized such that the reservoir 210 is configured to hold a small amount of urine as may be released due to incontinence. In some implementations, the reservoir 210 can be sized such that the reservoir 210 is configured to hold a large amount of urine as may be released during voiding of a full bladder. In some implementations, the reservoir 210 can be sized such that the reservoir is configured to collect and hold a small or large amount of urine while the urine is simultaneously removed via, for example, gravity and/or a pump, such as the vacuum source 270. Said another way, the reservoir 210 can function as a sump and be sized such that the reservoir 210 can form a portion of a passageway for urine from the permeable membrane 230, through the permeable support 240, through the reservoir 210, and out of the outlet 220. In a condition where the flow rate of urine into the assembly 202 via the permeable membrane 230 is greater than the flow rate of urine through the discharge line 222, a temporary backup of urine may occur in the reservoir 210. Thus, the reservoir 210 can be sized to contain a volume of fluid that may temporarily accumulate due to the difference in flow rates into and out of the assembly 202.
Although the outlet 220 is shown as extending from the side of the reservoir 210, in some implementations, the outlet 220 can extend from the bottom of the reservoir 210.
The cushion assembly 280 can include a membrane layer 282 and a support layer 284 (also referred to herein as a “bed of porous material”). The membrane layer 282 can be formed of the same or a similar material as the permeable membrane 230 and can have the same or similar properties as the permeable membrane 230. For example, the membrane layer 282 can be configured to wick fluid (e.g., urine) away from a urethral opening of a user when a urethral opening of a user is position near or in contact with the membrane layer 282. The membrane layer 282 can also be permeable such that fluid (e.g., urine) can flow through the membrane layer 282 and to the permeable membrane 230 and/or the permeable support 240, into the reservoir 210, and through the outlet 220. The support layer 284 can be formed of the same or a similar material as the permeable support 240 and can have the same or similar properties as the permeable support 240. For example, the support layer 284 can be configured to maintain the membrane layer 282 near or in contact with the head of a user's penis when the head of the user's penis is disposed within the cavity 252 of the assembly 202. The support layer 284 can also be permeable such that fluid (e.g., urine) can flow through the membrane layer 282, through the support layer 284, and to the permeable membrane 230 and/or the permeable support 240, into the reservoir 210, and through the outlet 220. The cushion assembly 280 can be arranged within the impermeable casing 250 such that the cushion assembly 280 forms a boundary of the cavity 252 (e.g., the bottom of the cavity 252). The cushion assembly 280 can be positioned along a bottom surface of the impermeable casing 250 such that a user's penis can be placed in contact with the cushion assembly 280 and/or such that urine flowing from a user's urethral opening into the cavity 252 can flow into the cushion assembly 280 thereby reducing splashing. In some implementations, the cushion assembly 280 (and specifically the membrane layer 282) can be disposed within the impermeable casing 250 such that the cushion assembly 280 contacts the permeable membrane 230.
The method 300 further includes, at 306, disposing the urine collecting apparatus in operative relationship with the urethral opening of the user, with a head of a penis of a male user (e.g. human or animal) disposed through an opening and into a cavity at least partially defined by a membrane of the urine collecting apparatus. The urine collecting apparatus can be the same or similar in structure and/or function to any of the urine collecting apparatus described herein, such as, for example, the assembly 102 in
The method 300 also includes, at 308, allowing urine discharged from the penis to be received into the cavity, through the membrane, through the support, and into the reservoir.
The method 300 also includes, at 310, allowing the received urine to be withdrawn from the reservoir via the tube and out of the fluid discharge end of the tube.
The method 300 optionally includes, at 312, allowing the withdrawn urine to be collected in the fluid receptacle.
The method 300 optionally includes, at 314, removing the urine collecting apparatus from the penis of the user. Thus, the urine collecting apparatus can capture and transport urine from a user without having to attach a catheter to the urethral opening of the user's penis. In some implementations, the urine can flow against gravity during collection.
Finally, the method 300 optionally includes, at 316, disposing a second urine collecting apparatus in operative relationship with the urethral opening of the user, with the head of the penis of the user disposed through the opening and into the cavity of the urine collecting apparatus.
More specifically, the impermeable casing 450 can define an interior region accessible via the opening 432. The permeable membrane 430 and the permeable support 440 can be disposed within the interior region of the impermeable casing 450. The impermeable casing 450 can be any suitable shape. For example, in some implementations, the impermeable casing 450 can be bowl-shaped. In some implementations, the impermeable casing 450 can include a bottom surface and at least one sidewall. In some implementations, the opening 432 can be opposite a bottom surface of the impermeable casing 450. In some implementations, the opening 432 can be any suitable shape and/or size. In some implementations, the impermeable casing 450 can optionally include a lip 456 such that the opening 432 is bounded and defined at least partially by the lip 456. The lip 456 can partially or completely surround the opening 432. In some implementations, the lip 456 can be shaped and sized such that the lip 456 can reduce the potential of urine flowing out of the opening 432 and/or such that the risk of splashing of urine through the opening 432 is reduced.
In some implementations, the opening 432 has a width and/or length similar in size to the diameter of a user's penis. In some implementations, the opening 432 is larger in width and/or length than the diameter than a user's penis. In some implementations, the opening 432 can be, for example, circular or ovalular. In some implementations, the opening 432 can have any suitable shape. Similarly, the impermeable casing 450 can have any suitable shape and/or perimeter shape, such as the shape of, for example, an oblong, square, triangle, circle, oval, or an irregular shape. For example, the opening 432 (and the impermeable casing 450) can have a rounded or semi-circular first portion and a second portion that tapers from a first side adjacent to the first portion having a first width to a second width smaller than the first width. In some implementations, the shape of the opening 432 can be the same or similar as the perimeter shape of the top of the impermeable casing 450.
In some implementations, the permeable support 440 can have a bottom side with a periphery. The periphery can be secured to the impermeable casing 450. In some implementations, the periphery can be secured (e.g., via adhesive) to a portion of the impermeable casing 450 adjacent a top edge of the impermeable casing. In some implementations, the impermeable casing 450 can extend upward beyond the location to which the periphery of the permeable support 540 is attached. In some implementations, the impermeable casing 450 can be attached to the permeable support 440 via any suitable retention mechanism, such as, for example, retainer clips or other fasteners. In some implementations, the permeable support 440 and the permeable membrane 430 can be placed within the impermeable casing without additional coupling mechanisms.
The impermeable layer 450 can be impermeable to fluid, such as, for example, urine. In some implementations, the impermeable layer 450 can have a fluid transportation function and can assist in directing fluid towards the reservoir 410 and/or through the outlet 420 of the reservoir 410. In some implementations, the impermeable layer 450 can be formed as an integral, unitary structure. In other implementations, the impermeable layer 450 can be a multi-piece structure. The impermeable layer 450 can be a pre-molded (e.g., injection or blow molded) component. Alternatively, the impermeable layer 450 can be formed of a material, such as elongate strips of an adhesive tape, wrapped around at least a portion of the reservoir 410, a portion of the permeable support 440, and/or a portion of the permeable membrane 430. In some embodiments, the impermeable layer 450 can be formed of cardboard, pressed paper, and/or coated paper. In some embodiments, the impermeable layer 450 can be flexible.
The permeable membrane 430 can be formed of a material that has permeable properties with respect to liquids such as urine. The permeable properties can be wicking, capillary action, diffusion, or other similar properties or processes, and are referred to herein as “permeable” and/or “wicking.” The permeable membrane 430 can have a high absorptive rate and a high permeation rate such that urine can be rapidly absorbed by the permeable membrane 430 and/or transported through the permeable membrane 430. In some implementations, the permeable membrane 430 can be flexible. In some implementations, the permeable membrane 430 can be a ribbed knit fabric. In some implementations, the permeable membrane 430 can include and/or have the moisture-wicking characteristic of gauze, felt, terrycloth, thick tissue paper, and/or a paper towel. In some implementations, the permeable membrane 430 can be soft and/or minimally abrasive such that the permeable membrane 430 does not irritate the skin of the user. The permeable membrane 430 can be configured to wick fluid away from the urethral opening and/or the skin of the user such that the dampness of the skin of the user is lessened and infections are prevented. Additionally, the wicking properties of the permeable membrane 430 can help prevent urine from leaking or flowing beyond the assembly (e.g., out of opening 432) onto, for example, a bed. In some implementations, the permeable membrane 430 can be formed of fine denier polyester fibers coated with a thermoplastic water-based binder system. The tensile strength can be, for example, about 45 lbs/inch2 (measured using an Instron test method). The weight of a permeable membrane can be, for example, about 12 grams (measured using the Mettler Gram Scale). The thickness per ten permeable membranes can be, for example, about 2.5″ (measured using the Gustin-Bacon/Measure-Matic).
The permeable support 440 can be positioned relative to the permeable membrane 430 such that the permeable support 440 maintains the permeable membrane 430 in a particular shape and allows for fluid, such as, for example, urine, to flow through the permeable membrane 430, through the permeable support 440, and into the reservoir 410. In some implementations, the permeable membrane 430 can be disposed on a first, upper side of the permeable support 440, and the second, bottom side of the permeable support 440 can define a boundary of the reservoir 410. In some implementations, the permeable support 440 can have a concave shape such that, when disposed within the impermeable casing 450, the cavity 452 has a concave bottom. When the permeable membrane 430 is disposed on the permeable support 440, the permeable membrane 430 can define a portion of the bottom and/or side boundaries of the cavity 452. When the permeable support 440 and the permeable membrane 430 are disposed within the impermeable casing 450, the cavity 452 can be aligned with the opening 432 of the impermeable casing 450. The reservoir 410 can be defined by the permeable support 440 and the impermeable casing 450 such that the reservoir 410 is concave and has any suitable shape and/or dimensions.
In some implementations, the permeable support 440 and/or the permeable membrane 430 can be any suitable shape and/or size. In some implementations, the permeable support 440 and the permeable membrane 430 can have the same or similar shape and dimensions. In some implementations, the permeable support 440 and/or the permeable membrane 430 can be shaped such that the outer perimeter of the permeable support 440 and/or the permeable membrane 430 can be the same or similar to the outer perimeter of the top of the impermeable casing 450 and/or the opening 432. In some implementations, the dimensions of the permeable support 440 and/or the permeable membrane 430 can be sized such that the cavity 452 can receive a penis of a user such that a head of the penis can be partially or fully disposed within the cavity 452 (i.e., the shaft of the penis can be disposed within the opening 432 and the head of the penis can be fully disposed within the cavity 452, or the urethral opening of the head of the penis can be disposed within the cavity 452 and the head can be partially disposed within the cavity 452 and partially outside the cavity 452, with the opening 432 surrounding a portion of the head). In some implementations, the cavity 452 can be dimensioned to receive a head of a penis of a user such that urine can be received from the urethral opening of the penis within the cavity 452, by the permeable membrane 430, and/or by the permeable support 440 without urine splashing out of the opening 432.
In some implementations, the permeable support 440 can be configured to maintain the permeable membrane 430 against the skin of a penis of a user and/or near a urethral opening of a user. For example, the permeable support 440 can be shaped and sized such that the cavity 452 is slightly larger than a head or tip of a penis of a user. The permeable support 440 can include a portion having a curved or convex shape in contact with the permeable membrane 430 such that the permeable membrane 430 is also curved or convex. The permeable support 440 can support the permeable membrane 430 such that the permeable membrane 430 can rest against the skin of the head or tip of the penis with the urethral opening directed toward a bottom surface of the impermeable casing 450, and thus creating a comfortable and at least partially enclosed interface for engagement with the area of the body (e.g., the head and/or neck of a penis of a user) near the urethral opening.
In some implementations, the permeable support 440 can be made of a rigid plastic. In some implementations, the permeable support 440 can have any suitable shape and be formed of any suitable material. For example, the permeable support 440 can be flexible. Additionally, the permeable support 440 can be formed of aluminum, a composite of plastic and aluminum, some other metal and/or a composite of plastic and another metal. In some implementations, the permeable support 440 can be formed of a natural material, such as, for example, plant fibers (e.g., Greener Clean manufactured by 3M®). The natural material can include openings that allow fluid to flow through the natural material. In some embodiments, the permeable support 440 can be formed of perforated coated paper, such as tubular waxed paper.
The permeable support 440 can define one or more openings (e.g., an array of openings) to allow for fluid flow from the permeable membrane 430 to the reservoir 410. In some implementations, the permeable support 440 can include membrane supports (e.g., struts) extending across an opening such that the opening is divided into an array of distinct slot-shaped openings. The membrane supports can be used to support the permeable membrane 430. For example, the membrane supports can maintain the shape of the permeable membrane 430 against the skin of a penis of a user and/or near a urethral opening of a user such that urine flowing from the urethral opening contacts and travels through the permeable membrane 430. In some implementations, the permeable support 440 can define several openings having a variety of shapes, such as a plurality of round openings. In some implementations, the permeable support 440 can be formed of spun plastic (e.g., non-woven permeable nylon and polyester webbing) such that the permeable support 440 can have many openings. In some implementations, the permeable support 440 can be formed of a porous material. For example, the permeable support 440 can be a porous glass container defining fits. In other implementations, the permeable support 440 can define an opening in the permeable support 440 and the opening can be covered by a mesh screen defining many smaller openings. In some embodiments, the reservoir 410 can include any spaces and/or openings defined within the permeable support 440 (e.g., spaces within porous material or defined within spun plastic material).
The reservoir 410 can be any suitable shape and/or have any diameter (or other dimension) suitable for receiving and transporting urine during use of the system 400. In some implementations, the reservoir 410 can be sized such that the reservoir 410 is capable of collecting and temporarily holding a large or small amount of urine until the urine can be removed from the reservoir via the outlet 420. For example, the reservoir 410 can be sized such that the reservoir 410 is configured to hold a small amount of urine as may be released due to incontinence. In some implementations, the reservoir 410 can be sized such that the reservoir 410 is configured to hold a large amount of urine as may be released during voiding of a full bladder. In some implementations, the reservoir 410 can be sized such that the reservoir is configured to collect and hold a small or large amount of urine while the urine is simultaneously removed via, for example, gravity and/or a pump, such as the vacuum source 470. Said another way, the reservoir 410 can function as a sump and be sized such that the reservoir 410 can form a portion of a passageway for urine from the permeable membrane 430, through the permeable support 440, through the reservoir 410, and out of the outlet 420. In a condition where the flow rate of urine into the assembly 402 via the permeable membrane 430 is greater than the flow rate of urine through the discharge line 422, a temporary backup of urine may occur in the reservoir 410. Thus, the reservoir 410 can be sized to contain a volume of fluid that may temporarily accumulate due to the difference in flow rates into and out of the assembly 402.
Although the outlet 420 is shown as extending from the side of the reservoir 410, in some implementations, the outlet 420 can extend from the bottom of the reservoir 410.
The external receptacle 460, via the discharge line 422, can collect fluid exiting the reservoir 410 through the outlet 420. The external receptacle 460 can be a sealed container. In some implementations, the external receptacle 460 can be disposable. In some implementations, the external receptacle 460 can be configured to be sterilized and reused.
In some implementations, gravity can cause fluid within the reservoir 410 to follow a flow path (i.e., the fluid flow path including the outlet 420 and the discharge line 422) from the reservoir 410 to the external receptacle 460. In some implementations, the vacuum source 470 can assist and/or provide the pressure differential needed to draw fluid voided from the urethral opening of a user into the permeable support 440, into the reservoir 410, and from the reservoir 410 into the external receptacle 460. The vacuum source 470 can be fluidically coupled to the external receptacle 460 via a vacuum line 424 such that gaseous fluid is drawn from the external receptacle 460 via the vacuum line 424. As a result of the decrease in pressure within the external receptacle 460 caused by the drawing of gaseous fluid out of the external receptacle 460, liquid and/or gaseous fluid can be drawn from the reservoir 410, through the outlet 420, through the discharge line 422, and into the external receptacle 460. In some implementations, the vacuum source 470 can apply sufficient suction to capture all or substantially all of the urine voided by a user in a variety of positions (e.g., when a male user is lying on his side or back).
The vacuum source 470 can have a sufficiently high vacuum strength and air volume transport rate such that rapid air and liquid aspiration is maintained over a portion of or the entire permeable membrane 430. In some implementations, the one or more openings of the permeable support 440 are distributed over an area that is slightly larger than the area of the permeable membrane 430 that is configured to be wetted by urine flow in operation. Thus, the partial vacuum created by the vacuum source 470 in combination with the one or more openings of the permeable support 440 and the permeable membrane 430 can draw the urine contacting the permeable membrane 430 into the assembly 402 and, specifically, into the reservoir 410. In some implementations, however, the one or more openings of the permeable support 440 should not be distributed over too large of an area of the permeable support 440 because the partial vacuum strength may be reduced, thereby reducing the urine collection rate and the efficiency of the system 400.
In some implementations, the vacuum source 470 can be the same or similar in structure and or function to the vacuum source 170 described above with respect to the system 100 shown in
Although described as being intended for use by an adult male, in some implementations the system 400 can be used in adult, pediatric, male, female, and veterinary applications for animals of different species and sizes. In female applications, the assembly 402 can be placed between the legs or labia of the user and held snugly against the external urethra by the pressure of friction from the user's body, by the pressure of the legs or by such means as an undergarment, elastic strips, and/or adhesive tape. In male applications, the assembly 402 can be placed such that a penis of a user is disposed within the assembly 402 (e.g., within a cavity formed within the assembly 402). A male user can use the assembly 402 in any suitable position, such as, for example, while lying on his back, lying on his side, sitting, or standing. In some implementations, the head of the penis of the male user can be placed in contact with the permeable membrane 430 during urination. In some implementations, the head of the penis of the male user can be disposed at least partially within the cavity 452, but not placed in contact with the permeable membrane 430 during urination.
The permeable support 540 and the permeable membrane 530 can be arranged such that the impermeable membrane 550 and the permeable support 540 and/or the permeable membrane 530 collectively define a cavity 552 within the permeable membrane 530. The impermeable casing 550 can direct fluid toward the reservoir 510 and/or reduce and/or prevent fluid from exiting the assembly 502 except via the outlet 520. In some implementations, the assembly 502 can be arranged such that a fluid can flow through the opening 532, into the cavity 552, through the permeable membrane 530, through the permeable support 540, into the reservoir 510, and out of the outlet 520. In some implementations, the assembly 502 can be arranged such that a user's penis can be inserted through the opening 532 such that the user's urethral opening is disposed within the cavity 552 and a fluid can flow from the user's urethral opening, into the cavity 552, through the permeable membrane 530, through the permeable support 540, into the reservoir 510, and out of the outlet 520. A discharge line 522 (e.g., a tube) (also referred to herein as a “received tube”) can extend through the outlet 520. As shown in
More specifically, the impermeable casing 550 can define an interior region accessible via the opening 532. The permeable membrane 530 and the permeable support 540 can be disposed within the interior region of the impermeable casing 550. The impermeable casing 550 can be any suitable shape. For example, in some implementations, the impermeable casing 550 can be bowl-shaped. As shown in
As shown in
The impermeable layer 550 can be impermeable to fluid, such as, for example, urine. In some implementations, the impermeable layer 550 can have a fluid transportation function and can assist in directing fluid towards the reservoir 510 and/or through the outlet 520 of the reservoir 510. In some implementations, the impermeable layer 550 can be formed as an integral, unitary structure. In other implementations, the impermeable layer 550 can be a multi-piece structure. The impermeable layer 550 can be a pre-molded (e.g., injection or blow molded) component. Alternatively, the impermeable layer 550 can be formed of a material, such as elongate strips of an adhesive tape, wrapped around at least a portion of the reservoir 510, a portion of the permeable support 540, and/or a portion of the permeable membrane 530. In some embodiments, the impermeable layer 550 can be formed of cardboard, pressed paper, and/or coated paper. In some embodiments, the impermeable layer 550 can be flexible.
The permeable membrane 530 can be formed of a material that has permeable properties with respect to liquids such as urine. The permeable properties can be wicking, capillary action, diffusion, or other similar properties or processes, and are referred to herein as “permeable” and/or “wicking.” The permeable membrane 530 can have a high absorptive rate and a high permeation rate such that urine can be rapidly absorbed by the permeable membrane 530 and/or transported through the permeable membrane 530. In some implementations, the permeable membrane 530 can be flexible. In some implementations, the permeable membrane 530 can be a ribbed knit fabric. In some implementations, the permeable membrane 530 can include and/or have the moisture-wicking characteristic of gauze, felt, terrycloth, thick tissue paper, and/or a paper towel. In some implementations, the permeable membrane 530 can be soft and/or minimally abrasive such that the permeable membrane 530 does not irritate the skin of the user. The permeable membrane 530 can be configured to wick fluid away from the urethral opening and/or the skin of the user such that the dampness of the skin of the user is lessened and infections are prevented. Additionally, the wicking properties of the permeable membrane 530 can help prevent urine from leaking or flowing beyond the assembly (e.g., out of opening 532) onto, for example, a bed. In some implementations, the permeable membrane 530 can be formed of fine denier polyester fibers coated with a thermoplastic water-based binder system. The tensile with the Webb direction can be, for example, about 45 lbs/inch2 measured using an Instron test method. The weight per permeable membrane can be, for example, about 12 grams measured using the Mettle Gram Scale. The thickness per ten permeable membrane can be, for example, about 2.5″, measured using the Gustin-Bacon/Measure-Matic.
The permeable support 540 can be positioned relative to the permeable membrane 530 such that the permeable support 540 maintains the permeable membrane 530 in a particular shape and allows for fluid, such as, for example, urine, to flow through the permeable membrane 530, through the permeable support 540, and into the reservoir 510. In some implementations, the permeable membrane 530 can be disposed on a first, upper side of the permeable support 540, and the second, bottom side of the permeable support 540 can define a boundary of the reservoir 510. As shown in
In some implementations, the permeable support 540 and/or the permeable membrane 530 can be any suitable shape and/or size. In some implementations, the permeable support 540 and the permeable membrane 530 can have the same or similar shape and dimensions. In some implementations, the permeable support 540 and/or the permeable membrane 530 can be shaped such that the outer perimeter of the permeable support 540 and/or the permeable membrane 530 can be the same or similar to the outer perimeter of the top of the impermeable casing 550 and/or the opening 532. In some implementations, the dimensions of the permeable support 540 and/or the permeable membrane 530 can be sized such that the cavity 552 can receive a penis of a user such that a head of the penis can be partially or fully disposed within the cavity 552 (i.e., the shaft of the penis can be disposed within the opening 532 and the head of the penis can be fully disposed within the cavity 552, or the urethral opening of the head of the penis can be disposed within the cavity 552 and the head can be partially disposed within the cavity 552 and partially outside the cavity 552, with the opening 532 surrounding a portion of the head). In some implementations, the cavity 552 can be dimensioned to receive a head of a penis of a user such that urine can be received from the urethral opening of the penis within the cavity 552, by the permeable membrane 530, and/or by the permeable support 540 without urine splashing out of the opening 532.
In some implementations, the permeable support 540 can be configured to maintain the permeable membrane 530 against the skin of a penis of a user and/or near a urethral opening of a user. For example, the permeable support 540 can be shaped and sized such that the cavity 552 is slightly larger than a head or tip of a penis of a user. The permeable support 540 can include a portion having a curved or convex shape in contact with the permeable membrane 530 such that the permeable membrane 530 is also curved or convex. The permeable support 540 can support the permeable membrane 530 such that the permeable membrane 530 can rest against the skin of the head or tip of the penis with the urethral opening directed toward a bottom surface of the impermeable casing 550, and thus creating a comfortable and at least partially enclosed interface for engagement with the area of the body (e.g., the head and/or neck of a penis of a user) near the urethral opening.
In some implementations, the permeable support 540 can be made of a rigid plastic. In some implementations, the permeable support 540 can have any suitable shape and be formed of any suitable material. For example, the permeable support 540 can be flexible. Additionally, the permeable support 540 can be formed of aluminum, a composite of plastic and aluminum, some other metal and/or a composite of plastic and another metal. In some implementations, the permeable support 540 can be formed of a natural material, such as, for example, plant fibers (e.g., Greener Clean manufactured by 3M®). The natural material can include openings that allow fluid to flow through the natural material. In some embodiments, the permeable support 540 can be formed of perforated coated paper, such as tubular waxed paper.
The permeable support 540 can define one or more openings (e.g., an array of openings) to allow for fluid flow from the permeable membrane 530 to the reservoir 510. In some implementations, the permeable support 540 can include membrane supports (e.g., struts) extending across an opening such that the opening is divided into an array of distinct slot-shaped openings. The membrane supports can be used to support the permeable membrane 530. For example, the membrane supports can maintain the shape of the permeable membrane 530 against the skin of a penis of a user and/or near a urethral opening of a user such that urine flowing from the urethral opening contacts and travels through the permeable membrane 530. In some implementations, the permeable support 540 can define several openings having a variety of shapes, such as a plurality of round openings. In some implementations, the permeable support 540 can be formed of spun plastic (e.g., non-woven permeable nylon and polyester webbing) such that the permeable support 540 can have many openings. In some implementations, the permeable support 540 can be formed of a porous material. For example, the permeable support 540 can be a porous glass container defining frits. In other implementations, the permeable support 540 can define an opening in the permeable support 540 and the opening can be covered by a mesh screen defining many smaller openings. In some embodiments, the reservoir 510 can include any spaces and/or openings defined within the permeable support 540 (e.g., spaces within porous material or defined within spun plastic material).
The reservoir 510 can be any suitable shape and/or have any diameter (or other dimension) suitable for receiving and transporting urine during use of a system including assembly 502. In some implementations, the reservoir 510 can be sized such that the reservoir 510 is capable of collecting and temporarily holding a large or small amount of urine until the urine can be removed from the reservoir via the outlet 520. For example, the reservoir 510 can be sized such that the reservoir 510 is configured to hold a small amount of urine as may be released due to incontinence. In some implementations, the reservoir 510 can be sized such that the reservoir 510 is configured to hold a large amount of urine as may be released during voiding of a full bladder. In some implementations, the reservoir 510 can be sized such that the reservoir is configured to collect and hold a small or large amount of urine while the urine is simultaneously removed via, for example, gravity and/or a pump, such as the vacuum source 570. Said another way, the reservoir 510 can function as a sump and be sized such that the reservoir 510 can form a portion of a passageway for urine from the permeable membrane 530, through the permeable support 540, through the reservoir 510, and out of the outlet 520. In a condition where the flow rate of urine into the assembly 502 via the permeable membrane 530 is greater than the flow rate of urine through the discharge line 522, a temporary backup of urine may occur in the reservoir 510. Thus, the reservoir 510 can be sized to contain a volume of fluid that may temporarily accumulate due to the difference in flow rates into and out of the assembly 502.
The method 600 further includes, at 606, disposing the urine collecting apparatus in operative relationship with the urethral opening of the user, with a head of a penis of a male user (e.g. human or animal) disposed through an opening and into a cavity defined by a fluid permeable membrane and a casing of the urine collecting apparatus. The urine collecting apparatus can be the same or similar in structure and/or function to any of the urine collecting apparatus described herein, such as, for example, the assembly 402 in
The method 600 also includes, at 608, allowing urine discharged from the penis to be received into the cavity, through the membrane, through the support, and into the reservoir.
The method 600 also includes, at 610, allowing the received urine to be withdrawn from the reservoir via the tube and out of the fluid discharge end of the tube.
The method 600 optionally includes, at 612, allowing the withdrawn urine to be collected in the fluid receptacle.
The method 600 optionally includes, at 614, removing the urine collecting apparatus from the penis of the user. Thus, the urine collecting apparatus can capture and transport urine from a user without having to attach a catheter to the urethral opening of the user's penis. In some implementations, the urine can flow against gravity during collection.
Finally, the method 600 optionally includes, at 616, disposing a second urine collecting apparatus in operative relationship with the urethral opening of the user, with the head of the penis of the user disposed through the opening and into the cavity of the urine collecting apparatus.
While various embodiments of the system, methods and devices have been described above, it should be understood that they have been presented by way of example only, and not limitation. Where methods and steps described above indicate certain events occurring in certain order, those of ordinary skill in the art having the benefit of this disclosure would recognize that the ordering of certain steps may be modified and such modifications are in accordance with the variations of the invention. Additionally, certain of the steps may be performed concurrently in a parallel process when possible, as well as performed sequentially as described above. The embodiments have been particularly shown and described, but it will be understood that various changes in form and details may be made.
For example, although various embodiments have been described as having particular features and/or combinations of components, other embodiments are possible having any combination or sub-combination of any features and/or components from any of the embodiments described herein. In addition, the specific configurations of the various components can also be varied. For example, the size and specific shape of the various components can be different than the embodiments shown, while still providing the functions as described herein.
This application is a continuation-in-part of and claims priority to and the benefit of U.S. patent application Ser. No. 15/221,106, filed Jul. 27, 2016, entitled “Male Urine Collection Device Using Wicking Material,” the disclosure of which is incorporated herein by reference in its entirety. This application is also a continuation-in-part of and claims priority to and the benefit of U.S. patent application Ser. No. 15/238,427, filed Aug. 16, 2016, entitled “Using Wicking Material to Collect Urine From a Male for Transport,” the disclosure of which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
1742080 | Jones | Dec 1929 | A |
2613670 | Sokolik | Oct 1952 | A |
2644234 | Earl | Jul 1953 | A |
2968046 | Duke | Jan 1961 | A |
3087938 | Hans et al. | Apr 1963 | A |
3198994 | Hildebrandt et al. | Aug 1965 | A |
3221742 | Egon | Dec 1965 | A |
3312981 | McGuire et al. | Apr 1967 | A |
3349768 | Keane | Oct 1967 | A |
3366116 | Huck | Jan 1968 | A |
3400717 | Bruce et al. | Sep 1968 | A |
3406688 | Bruce | Oct 1968 | A |
3511241 | Lee | May 1970 | A |
3512185 | Ellis | May 1970 | A |
3520300 | Flower | Jul 1970 | A |
3613123 | Langstrom | Oct 1971 | A |
3651810 | Ormerod | Mar 1972 | A |
3726277 | Hirschman | Apr 1973 | A |
3998228 | Poidomani | Dec 1976 | A |
4020843 | Kanall | May 1977 | A |
4022213 | Stein | May 1977 | A |
4200102 | Duhamel et al. | Apr 1980 | A |
4202058 | Anderson | May 1980 | A |
4233025 | Larson et al. | Nov 1980 | A |
4246901 | Frosch et al. | Jan 1981 | A |
4257418 | Hessner | Mar 1981 | A |
4270539 | Frosch et al. | Jun 1981 | A |
4352356 | Tong | Oct 1982 | A |
4360933 | Kimura et al. | Nov 1982 | A |
4365363 | Windauer | Dec 1982 | A |
4387726 | Denard | Jun 1983 | A |
4425130 | Desmarais | Jan 1984 | A |
4453938 | Brendling | Jun 1984 | A |
4457314 | Knowles | Jul 1984 | A |
4526688 | Schmidt, Jr. et al. | Jul 1985 | A |
4528703 | Kraus | Jul 1985 | A |
4581026 | Schneider | Apr 1986 | A |
4610675 | Triunfol | Sep 1986 | A |
4627846 | Ternstroem | Dec 1986 | A |
4631061 | Martin | Dec 1986 | A |
4650477 | Johnson | Mar 1987 | A |
4692160 | Nussbaumer | Sep 1987 | A |
4713066 | Komis | Dec 1987 | A |
4747166 | Kuntz | May 1988 | A |
4752944 | Conrads et al. | Jun 1988 | A |
4769215 | Ehrenkranz | Sep 1988 | A |
4772280 | Rooyakkers | Sep 1988 | A |
4790835 | Elias | Dec 1988 | A |
4791686 | Taniguchi et al. | Dec 1988 | A |
4795449 | Schneider et al. | Jan 1989 | A |
4799928 | Crowley | Jan 1989 | A |
4804377 | Hanifl et al. | Feb 1989 | A |
4820297 | Kaufman et al. | Apr 1989 | A |
4846909 | Klug et al. | Jul 1989 | A |
4882794 | Stewart, III | Nov 1989 | A |
4883465 | Brennan | Nov 1989 | A |
4886508 | Washington | Dec 1989 | A |
4886509 | Mattsson | Dec 1989 | A |
4889533 | Beecher | Dec 1989 | A |
4905692 | More | Mar 1990 | A |
4955922 | Terauchi | Sep 1990 | A |
4965460 | Tanaka et al. | Oct 1990 | A |
5002541 | Conkling et al. | Mar 1991 | A |
5004463 | Nigay | Apr 1991 | A |
5031248 | Kemper | Jul 1991 | A |
5049144 | Payton | Sep 1991 | A |
5071347 | Mcguire | Dec 1991 | A |
5084037 | Barnett | Jan 1992 | A |
5100396 | Zamierowski | Mar 1992 | A |
5147301 | Ruvio | Sep 1992 | A |
5195997 | Carns | Mar 1993 | A |
5203699 | McGuire | Apr 1993 | A |
5244458 | Takasu | Sep 1993 | A |
5294983 | Ersoz et al. | Mar 1994 | A |
5295983 | Kubo | Mar 1994 | A |
5300052 | Kubo | Apr 1994 | A |
5382244 | Telang | Jan 1995 | A |
5423784 | Metz | Jun 1995 | A |
5466229 | Elson et al. | Nov 1995 | A |
5478334 | Bernstein | Dec 1995 | A |
5499977 | Marx | Mar 1996 | A |
D373928 | Green | Sep 1996 | S |
5618277 | Goulter | Apr 1997 | A |
5628735 | Skow | May 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5674212 | Osborn, III et al. | Oct 1997 | A |
5678564 | Lawrence et al. | Oct 1997 | A |
5678654 | Uzawa | Oct 1997 | A |
5687429 | Rahlff | Nov 1997 | A |
5695485 | Duperret et al. | Dec 1997 | A |
5752944 | Dann et al. | May 1998 | A |
5772644 | Bark et al. | Jun 1998 | A |
5827247 | Kay | Oct 1998 | A |
5827250 | Fujioka et al. | Oct 1998 | A |
5827257 | Fujioka et al. | Oct 1998 | A |
D401699 | Herchenbach et al. | Nov 1998 | S |
5865378 | Hollinshead et al. | Feb 1999 | A |
5887291 | Bellizzi | Mar 1999 | A |
5894608 | Birbara | Apr 1999 | A |
D409303 | Oepping | May 1999 | S |
5911222 | Lawrence et al. | Jun 1999 | A |
5957904 | Holland | Sep 1999 | A |
5972505 | Phillips et al. | Oct 1999 | A |
6059762 | Boyer et al. | May 2000 | A |
6063064 | Tuckey et al. | May 2000 | A |
6105174 | Karlsten et al. | Aug 2000 | A |
6113582 | Dwork | Sep 2000 | A |
6117163 | Bierman | Sep 2000 | A |
6123398 | Arai et al. | Sep 2000 | A |
6129718 | Wada et al. | Oct 2000 | A |
6131964 | Sareshwala | Oct 2000 | A |
6164569 | Hollinshead et al. | Dec 2000 | A |
6177606 | Etheredge | Jan 2001 | B1 |
6209142 | Mattsson et al. | Apr 2001 | B1 |
6248096 | Dwork et al. | Jun 2001 | B1 |
6311339 | Kraus | Nov 2001 | B1 |
6336919 | Davis et al. | Jan 2002 | B1 |
6338729 | Wada et al. | Jan 2002 | B1 |
6409712 | Dutari et al. | Jun 2002 | B1 |
6416500 | Wada et al. | Jul 2002 | B1 |
6475198 | Lipman et al. | Nov 2002 | B1 |
6479726 | Cole et al. | Nov 2002 | B1 |
6491673 | Palumbo et al. | Dec 2002 | B1 |
6508794 | Palumbo et al. | Jan 2003 | B1 |
6540729 | Wada et al. | Apr 2003 | B1 |
6547771 | Robertson et al. | Apr 2003 | B2 |
6569133 | Cheng et al. | May 2003 | B2 |
6592560 | Snyder et al. | Jul 2003 | B2 |
6620142 | Flueckiger | Sep 2003 | B1 |
6629651 | Male et al. | Oct 2003 | B1 |
6635038 | Scovel | Oct 2003 | B2 |
6685684 | Falconer | Feb 2004 | B1 |
6702793 | Sweetser et al. | Mar 2004 | B1 |
6706027 | Harvie et al. | Mar 2004 | B2 |
6732384 | Scott | May 2004 | B2 |
6740066 | Wolff et al. | May 2004 | B2 |
6764477 | Chen et al. | Jul 2004 | B1 |
6783519 | Samuelsson | Aug 2004 | B2 |
6814547 | Childers et al. | Nov 2004 | B2 |
6849065 | Schmidt et al. | Feb 2005 | B2 |
6857137 | Otto | Feb 2005 | B2 |
6885690 | Aggerstam et al. | Apr 2005 | B2 |
6888044 | Fell et al. | May 2005 | B2 |
6912737 | Ernest | Jul 2005 | B2 |
6918899 | Harvie | Jul 2005 | B2 |
6979324 | Bybordi et al. | Dec 2005 | B2 |
7018366 | Easter | Mar 2006 | B2 |
7066411 | Male et al. | Jun 2006 | B2 |
7125399 | Miskie | Oct 2006 | B2 |
7131964 | Harvie | Nov 2006 | B2 |
7135012 | Harvie | Nov 2006 | B2 |
7141043 | Harvie | Nov 2006 | B2 |
7171699 | Ernest et al. | Feb 2007 | B2 |
7171871 | Kozak | Feb 2007 | B2 |
7179951 | Krishnaswamy-mirle et al. | Feb 2007 | B2 |
7181781 | Trabold et al. | Feb 2007 | B1 |
7186245 | Cheng et al. | Mar 2007 | B1 |
7192424 | Cooper | Mar 2007 | B2 |
7220250 | Suzuki et al. | May 2007 | B2 |
7335189 | Harvie | Feb 2008 | B2 |
7358282 | Krueger et al. | Apr 2008 | B2 |
7390320 | Machida et al. | Jun 2008 | B2 |
7488310 | Yang | Feb 2009 | B2 |
D591106 | Dominique et al. | Apr 2009 | S |
7520872 | Biggie et al. | Apr 2009 | B2 |
D593801 | Wilson et al. | Jun 2009 | S |
7588560 | Dunlop | Sep 2009 | B1 |
7682347 | Parks et al. | Mar 2010 | B2 |
7695459 | Gilbert et al. | Apr 2010 | B2 |
7695460 | Wada et al. | Apr 2010 | B2 |
7699818 | Gilbert | Apr 2010 | B2 |
7699831 | Bengtson et al. | Apr 2010 | B2 |
7722584 | Tanaka et al. | May 2010 | B2 |
7727206 | Gorres | Jun 2010 | B2 |
7740620 | Gilbert et al. | Jun 2010 | B2 |
7749205 | Tazoe et al. | Jul 2010 | B2 |
7755497 | Wada et al. | Jul 2010 | B2 |
7766887 | Burns, Jr. et al. | Aug 2010 | B2 |
7833169 | Hannon | Nov 2010 | B2 |
7866942 | Harvie | Jan 2011 | B2 |
7871385 | Levinson et al. | Jan 2011 | B2 |
7875010 | Frazier et al. | Jan 2011 | B2 |
7901389 | Mombrinie | Mar 2011 | B2 |
7927320 | Goldwasser et al. | Apr 2011 | B2 |
7927321 | Marland | Apr 2011 | B2 |
7931634 | Swiecicki et al. | Apr 2011 | B2 |
7939706 | Okabe et al. | May 2011 | B2 |
7947025 | Buglino et al. | May 2011 | B2 |
7976519 | Bubb et al. | Jul 2011 | B2 |
7993318 | Olsson et al. | Aug 2011 | B2 |
8028460 | Williams | Oct 2011 | B2 |
8128608 | Thevenin | Mar 2012 | B2 |
8181651 | Pinel | May 2012 | B2 |
8211063 | Bierman et al. | Jul 2012 | B2 |
8221369 | Parks et al. | Jul 2012 | B2 |
8241262 | Mahnensmith | Aug 2012 | B2 |
8277426 | Wilcox et al. | Oct 2012 | B2 |
8287508 | Sanchez | Oct 2012 | B1 |
8303554 | Tsai et al. | Nov 2012 | B2 |
8337477 | Parks et al. | Dec 2012 | B2 |
D674241 | Bickert et al. | Jan 2013 | S |
8343122 | Gorres | Jan 2013 | B2 |
8353074 | Krebs | Jan 2013 | B2 |
D676241 | Merrill | Feb 2013 | S |
8388588 | Wada et al. | Mar 2013 | B2 |
8425482 | Khoubnazar | Apr 2013 | B2 |
8546639 | Wada et al. | Oct 2013 | B2 |
8551075 | Bengtson | Oct 2013 | B2 |
8568376 | Delattre et al. | Oct 2013 | B2 |
8585683 | Bengtson et al. | Nov 2013 | B2 |
D704330 | Cicatelli | May 2014 | S |
D704510 | Mason et al. | May 2014 | S |
D705423 | Walsh Cutler | May 2014 | S |
8715267 | Bengtson et al. | May 2014 | B2 |
8864730 | Conway et al. | Oct 2014 | B2 |
8936585 | Carson et al. | Jan 2015 | B2 |
D729581 | Boroski | May 2015 | S |
9028460 | Medeiros | May 2015 | B2 |
9173602 | Gilbert | Nov 2015 | B2 |
9173799 | Tanimoto et al. | Nov 2015 | B2 |
9248058 | Conway et al. | Feb 2016 | B2 |
9308118 | Dupree et al. | Apr 2016 | B1 |
9480595 | Baham et al. | Nov 2016 | B2 |
D777941 | Piramoon | Jan 2017 | S |
D804907 | Sandoval | Dec 2017 | S |
D814239 | Arora | Apr 2018 | S |
10226376 | Sanchez et al. | Mar 2019 | B2 |
10335121 | Desai | Jul 2019 | B2 |
10376406 | Newton | Aug 2019 | B2 |
10390989 | Sanchez et al. | Aug 2019 | B2 |
10478356 | Griffin | Nov 2019 | B2 |
20010054426 | Knudson et al. | Dec 2001 | A1 |
20020019614 | Woon | Feb 2002 | A1 |
20020026161 | Grundke | Feb 2002 | A1 |
20020087131 | Wolff et al. | Jul 2002 | A1 |
20020189992 | Schmidt et al. | Dec 2002 | A1 |
20030004436 | Schmidt et al. | Jan 2003 | A1 |
20030120178 | Heki | Jun 2003 | A1 |
20030181880 | Schwartz | Sep 2003 | A1 |
20030195484 | Harvie | Oct 2003 | A1 |
20030233079 | Parks et al. | Dec 2003 | A1 |
20040006321 | Cheng et al. | Jan 2004 | A1 |
20040056122 | Male et al. | Mar 2004 | A1 |
20040127872 | Petryk et al. | Jul 2004 | A1 |
20040128749 | Scott | Jul 2004 | A1 |
20040143229 | Easter | Jul 2004 | A1 |
20040191919 | Unger et al. | Sep 2004 | A1 |
20040207530 | Nielsen | Oct 2004 | A1 |
20040236292 | Tazoe et al. | Nov 2004 | A1 |
20040254547 | Okabe et al. | Dec 2004 | A1 |
20050010182 | Parks et al. | Jan 2005 | A1 |
20050033248 | Machida et al. | Feb 2005 | A1 |
20050070861 | Okabe et al. | Mar 2005 | A1 |
20050070862 | Tazoe et al. | Mar 2005 | A1 |
20050097662 | Leimkuhler et al. | May 2005 | A1 |
20050101924 | Elson et al. | May 2005 | A1 |
20050177070 | Levinson et al. | Aug 2005 | A1 |
20050197639 | Mombrinie | Sep 2005 | A1 |
20050277904 | Chase et al. | Dec 2005 | A1 |
20050279359 | LeBlanc et al. | Dec 2005 | A1 |
20060004332 | Marx | Jan 2006 | A1 |
20060015080 | Mahnensmith | Jan 2006 | A1 |
20060015081 | Suzuki et al. | Jan 2006 | A1 |
20060155214 | Wightman | Jul 2006 | A1 |
20060200102 | Cooper | Sep 2006 | A1 |
20060229576 | Conway et al. | Oct 2006 | A1 |
20060231648 | Male et al. | Oct 2006 | A1 |
20060235359 | Marland | Oct 2006 | A1 |
20070006368 | Key et al. | Jan 2007 | A1 |
20070038194 | Wada et al. | Feb 2007 | A1 |
20070117880 | Elson et al. | May 2007 | A1 |
20070135786 | Schmidt et al. | Jun 2007 | A1 |
20070191804 | Coley | Aug 2007 | A1 |
20070214553 | Carromba et al. | Sep 2007 | A1 |
20070266486 | Ramirez | Nov 2007 | A1 |
20080004576 | Tanaka et al. | Jan 2008 | A1 |
20080015527 | House | Jan 2008 | A1 |
20080033386 | Okabe et al. | Feb 2008 | A1 |
20080091153 | Harvie | Apr 2008 | A1 |
20080091158 | Yang | Apr 2008 | A1 |
20080234642 | Patterson et al. | Sep 2008 | A1 |
20080281282 | Finger et al. | Nov 2008 | A1 |
20080287894 | Van Den Heuvel et al. | Nov 2008 | A1 |
20090025717 | Pinel | Jan 2009 | A1 |
20090056003 | Ivie et al. | Mar 2009 | A1 |
20090192482 | Dodge, II et al. | Jul 2009 | A1 |
20090234312 | Otoole et al. | Sep 2009 | A1 |
20090251510 | Noro et al. | Oct 2009 | A1 |
20090264840 | Virginio | Oct 2009 | A1 |
20090270822 | Medeiros | Oct 2009 | A1 |
20090281510 | Fisher | Nov 2009 | A1 |
20100004612 | Thevenin | Jan 2010 | A1 |
20100121289 | Parks et al. | May 2010 | A1 |
20100185168 | Graauw et al. | Jul 2010 | A1 |
20100198172 | Wada et al. | Aug 2010 | A1 |
20100211032 | Tsai et al. | Aug 2010 | A1 |
20100241104 | Gilbert | Sep 2010 | A1 |
20100263113 | Shelton et al. | Oct 2010 | A1 |
20100310845 | Bond et al. | Dec 2010 | A1 |
20110028922 | Kay et al. | Feb 2011 | A1 |
20110034889 | Smith | Feb 2011 | A1 |
20110040267 | Wada et al. | Feb 2011 | A1 |
20110040271 | Rogers et al. | Feb 2011 | A1 |
20110054426 | Stewart et al. | Mar 2011 | A1 |
20110060300 | Weig et al. | Mar 2011 | A1 |
20110077495 | Gilbert | Mar 2011 | A1 |
20110172620 | Khambatta | Jul 2011 | A1 |
20110172625 | Wada et al. | Jul 2011 | A1 |
20110202024 | Cozzens | Aug 2011 | A1 |
20120035577 | Tomes et al. | Feb 2012 | A1 |
20120103347 | Wheaton et al. | May 2012 | A1 |
20120165768 | Sekiyama et al. | Jun 2012 | A1 |
20120165786 | Chappa et al. | Jun 2012 | A1 |
20120210503 | Anzivino et al. | Aug 2012 | A1 |
20120245542 | Suzuki et al. | Sep 2012 | A1 |
20120245547 | Wilcox et al. | Sep 2012 | A1 |
20120253303 | Suzuki et al. | Oct 2012 | A1 |
20120330256 | Wilcox et al. | Dec 2012 | A1 |
20130006206 | Wada et al. | Jan 2013 | A1 |
20130045651 | Esteves et al. | Feb 2013 | A1 |
20130053804 | Soerensen et al. | Feb 2013 | A1 |
20130096523 | Chang et al. | Apr 2013 | A1 |
20140031774 | Bengtson | Jan 2014 | A1 |
20140157499 | Suzuki et al. | Jun 2014 | A1 |
20140182051 | Tanimoto et al. | Jul 2014 | A1 |
20140196189 | Lee et al. | Jul 2014 | A1 |
20140348139 | Gomez Martinez | Nov 2014 | A1 |
20140352050 | Yao et al. | Dec 2014 | A1 |
20140371628 | Desai | Dec 2014 | A1 |
20150045757 | Lee et al. | Feb 2015 | A1 |
20150047114 | Ramirez | Feb 2015 | A1 |
20150135423 | Sharpe et al. | May 2015 | A1 |
20150157300 | Ealovega et al. | Jun 2015 | A1 |
20150209194 | Heyman | Jul 2015 | A1 |
20150359660 | Harvie | Dec 2015 | A1 |
20150366699 | Nelson | Dec 2015 | A1 |
20160029998 | Brister et al. | Feb 2016 | A1 |
20160038356 | Yao et al. | Feb 2016 | A1 |
20160058322 | Brister et al. | Mar 2016 | A1 |
20160100976 | Conway et al. | Apr 2016 | A1 |
20160106604 | Timm | Apr 2016 | A1 |
20160278662 | Brister et al. | Sep 2016 | A1 |
20160366699 | Zhang et al. | Dec 2016 | A1 |
20160367226 | Newton et al. | Dec 2016 | A1 |
20160367411 | Justiz et al. | Dec 2016 | A1 |
20160374848 | Sanchez | Dec 2016 | A1 |
20170007438 | Harvie | Jan 2017 | A1 |
20170143534 | Sanchez | May 2017 | A1 |
20170189225 | Voorhees et al. | Jul 2017 | A1 |
20170202692 | Laniado | Jul 2017 | A1 |
20170216081 | Accosta | Aug 2017 | A1 |
20170246026 | Laniado | Aug 2017 | A1 |
20170252014 | Siller Gonzalez et al. | Sep 2017 | A1 |
20170252202 | Sanchez et al. | Sep 2017 | A9 |
20170266031 | Sanchez et al. | Sep 2017 | A1 |
20170312116 | Laniado | Nov 2017 | A1 |
20170325788 | Ealovega et al. | Nov 2017 | A1 |
20170333244 | Laniado | Nov 2017 | A1 |
20170042748 | Griffin | Dec 2017 | A1 |
20170348139 | Newton et al. | Dec 2017 | A1 |
20170354532 | Holt | Dec 2017 | A1 |
20170367873 | Grannum | Dec 2017 | A1 |
20180008451 | Stroebech | Jan 2018 | A1 |
20180008804 | Laniado | Jan 2018 | A1 |
20180028349 | Newton et al. | Feb 2018 | A1 |
20180049910 | Newton | Feb 2018 | A1 |
20180064572 | Wiltshire | Mar 2018 | A1 |
20180200101 | Su | Jul 2018 | A1 |
20180228642 | Davis et al. | Aug 2018 | A1 |
20190038451 | Harvie | Feb 2019 | A1 |
20190142624 | Sanchez et al. | May 2019 | A1 |
20190224036 | Sanchez et al. | Jul 2019 | A1 |
20190314190 | Sanchez et al. | Oct 2019 | A1 |
20190365561 | Newton et al. | Dec 2019 | A1 |
20200046544 | Godinez et al. | Feb 2020 | A1 |
20200085610 | Cohn et al. | Mar 2020 | A1 |
Number | Date | Country |
---|---|---|
1533755 | Oct 2004 | CN |
1602825 | Apr 2005 | CN |
1720888 | Jan 2006 | CN |
101262836 | Sep 2008 | CN |
202184840 | Apr 2012 | CN |
103717180 | Apr 2014 | CN |
107847384 | Mar 2018 | CN |
9407554.9 | May 1995 | DE |
4443710 | Jun 1995 | DE |
102011103783 | Dec 2012 | DE |
9600118 | Nov 1996 | DK |
0032138 | Jul 1981 | EP |
0066070 | Dec 1982 | EP |
0119143 | Nov 1988 | EP |
0610638 | Aug 1994 | EP |
0613355 | Sep 1994 | EP |
1382318 | Jan 2004 | EP |
2180907 | May 2010 | EP |
2380532 | Oct 2011 | EP |
2879534 | Mar 2017 | EP |
3169292 | Nov 2019 | EP |
1467144 | Mar 1977 | GB |
2106395 | Apr 1983 | GB |
2148126 | Jul 1987 | GB |
2191095 | Dec 1987 | GB |
2199750 | Jul 1988 | GB |
2260907 | May 1993 | GB |
2462267 | Feb 2010 | GB |
2469496 | Oct 2010 | GB |
S5410596 | May 1979 | JP |
H0267530 | Mar 1990 | JP |
H02103871 | Apr 1990 | JP |
H0460220 | Feb 1992 | JP |
H05123349 | May 1993 | JP |
H11113946 | Apr 1999 | JP |
H11290365 | Oct 1999 | JP |
2000185068 | Jul 2000 | JP |
3087938 | Sep 2000 | JP |
2001054531 | Feb 2001 | JP |
2001054531 | Feb 2001 | JP |
2001276107 | Oct 2001 | JP |
2001276108 | Oct 2001 | JP |
2004267530 | Sep 2004 | JP |
2005066325 | Mar 2005 | JP |
2006026108 | Feb 2006 | JP |
3123547 | Jun 2006 | JP |
2006204868 | Aug 2006 | JP |
3132659 | May 2007 | JP |
4039641 | Nov 2007 | JP |
4747166 | May 2011 | JP |
2012523869 | Oct 2012 | JP |
2015092945 | May 2015 | JP |
3198994 | Jul 2015 | JP |
8101957 | Jul 1981 | WO |
8804558 | Jun 1988 | WO |
9104714 | Apr 1991 | WO |
9104714 | Jun 1991 | WO |
9220299 | Feb 1993 | WO |
9309736 | May 1993 | WO |
9309736 | Jun 1993 | WO |
9600096 | Jan 1996 | WO |
9830336 | Jul 1998 | WO |
0057784 | Oct 2000 | WO |
0145618 | Jun 2001 | WO |
0145621 | Jun 2001 | WO |
03071931 | Sep 2003 | WO |
03071931 | Feb 2004 | WO |
2004019836 | Mar 2004 | WO |
2005089687 | Sep 2005 | WO |
2005107661 | Nov 2005 | WO |
2007007845 | Jan 2007 | WO |
2007042823 | Apr 2007 | WO |
2008078117 | Jul 2008 | WO |
2009052496 | Apr 2009 | WO |
2009101738 | Aug 2009 | WO |
2010030122 | Jul 2010 | WO |
2011024864 | Mar 2011 | WO |
2011132043 | Oct 2011 | WO |
2013103291 | Jul 2013 | WO |
2013131109 | Sep 2013 | WO |
2014041534 | Mar 2014 | WO |
2015023599 | Feb 2015 | WO |
2015169403 | Nov 2015 | WO |
2015170307 | Nov 2015 | WO |
2016051385 | Apr 2016 | WO |
2016055989 | Apr 2016 | WO |
2016071894 | May 2016 | WO |
2016103242 | Jun 2016 | WO |
2016116915 | Jul 2016 | WO |
2016200088 | Dec 2016 | WO |
2017209779 | Dec 2017 | WO |
2017210524 | Dec 2017 | WO |
2018022414 | Feb 2018 | WO |
2018056953 | Mar 2018 | WO |
2018138513 | Aug 2018 | WO |
2018144463 | Aug 2018 | WO |
2018152156 | Aug 2018 | WO |
2018235065 | Dec 2018 | WO |
2019212949 | Nov 2019 | WO |
2019212954 | Nov 2019 | WO |
Entry |
---|
Corrected International Search Report and Written Opinion for International Application No. PCT/US2017/043025 dated Jan. 11, 2018. |
International Search Report and Written Opinion for International Application No. PCT/US2017/043025 dated Oct. 18, 2017. |
“Male Urinary Pouch External Collection Device”, http://www.hollister.com/en/products/Continence-Care-Products/Urine-Collectors/Urine-Collection-Accessories/Male-Urinary-Pouch-External-Collection-Device, last accessed Feb. 8, 2018. |
“Step by Step How Ur24 WorksHome”, http://medicalpatentur24.com, last accessed Dec. 6, 2017, Aug. 30, 2017, 4 pages. |
Advisory Action for U.S. Appl. No. 14/722,613 dated Mar. 4, 2019. |
Advisory Action for U.S. Appl. No. 14/952,591 dated Jun. 1, 2018. |
Advisory Action for U.S. Appl. No. 15/238,427 dated Apr. 10, 2019. |
AMXDmax In-Flight Bladder Relief; Omni Medical 2015; Omni Medical Systems, Inc. |
Corrected Notice of Allowability for U.S. Appl. No. 15/221,106 dated Jul. 2, 2019. |
Final Office Action for U.S. Appl. No. 14/722,613 dated Nov. 29, 2018. |
Final Office Action for U.S. Appl. No. 14/947,759 dated Apr. 8, 2016. |
Final Office Action for U.S. Appl. No. 14/952,591 dated Feb. 23, 2018. |
Final Office Action for U.S. Appl. No. 14/952,591 dated Nov. 1, 2019. |
Final Office Action for U.S. Appl. No. 15/171,968 dated Feb. 14, 2020. |
Final Office Action for U.S. Appl. No. 15/171,968 dated Mar. 19, 2019. |
Final Office Action for U.S. Appl. No. 15/221,106 dated Jan. 23, 2019. |
Final Office Action for U.S. Appl. No. 15/238,427 dated Jan. 2, 2019. |
Final Office Action for U.S. Appl. No. 15/260,103 dated Feb. 14, 2019. |
Final Office Action for U.S. Appl. No. 29/624,661 dated Feb. 18, 2020. |
International Search Report and Written Opinion for International Application No. PCT/US2018/015968 dated Apr. 6, 2018. |
International Search Report and Written Opinion for International Patent Application No. PCT/US16/49274, dated Dec. 1, 2016. |
International Search Report and Written Opinion from International Application No. PCT/US2017/035625 dated Aug. 15, 2017. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029608 dated Sep. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029609 dated Sep. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029610 dated Sep. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029611 dated Jul. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029613 dated Jul. 3, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029614 dated Sep. 26, 2019. |
International Search Report and Written Opinion from International Application No. PCT/US2019/029616 dated Aug. 30, 2019. |
Issue Notification for U.S. Appl. No. 15/221,106 dated Jul. 24, 2019. |
Issue Notification for U.S. Appl. No. 15/238,427 dated Jul. 24, 2019. |
Issue Notification for U.S. Appl. No. 15/260,103 dated Aug. 7, 2019. |
Issue Notification for U.S. Appl. No. 15/611,587 dated Feb. 20, 2019. |
Non-Final Office Action for U.S. Appl. No. 14/722,613 dated Jun. 13, 2019. |
Non-Final Office Action for U.S. Appl. No. 14/947,759, dated Mar. 17, 2016. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Aug. 1, 2017. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Mar. 20, 2020. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Mar. 21, 2019. |
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Sep. 28, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated Jun. 2018. |
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated Aug. 20, 2019. |
Non-Final Office Action for U.S. Appl. No. 15/221,106 dated Jun. 5, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/238,427 dated Aug. 8, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/260,103 dated Sep. 26, 2018. |
Non-Final Office Action for U.S. Appl. No. 15/611,587 dated Dec. 29, 2017. |
Non-Final Office Action for U.S. Appl. No. 15/611,587 dated Jul. 13, 2018. |
Non-Final Office Action for U.S. Appl. No. 29/624,661 dated Jul. 18, 2019. |
Notice of Allowance for U.S. Appl. No. 15/221,106 dated May 1, 2019. |
Notice of Allowance for U.S. Appl. No. 15/238,427 dated May 23, 2019. |
Notice of Allowance for U.S. Appl. No. 15/260,103 dated Jun. 7, 2019. |
Notice of Allowance for U.S. Appl. No. 15/611,587 dated Dec. 21, 2018. |
U.S. Appl. No. 15/171,968, filed Jun. 2, 2016. |
U.S. Appl. No. 15/221,106, filed Jul. 27, 2016. |
U.S. Appl. No. 16/369,676, filed Mar. 29, 2019. |
U.S. Appl. No. 16/433,773, filed Jun. 6, 2019. |
U.S. Appl. No. 16/449,039, filed Jun. 21, 2019. |
U.S. Appl. No. 16/452,145, filed Jun. 25, 2019. |
U.S. Appl. No. 16/452,258, filed Jun. 25, 2019. |
U.S. Appl. No. 16/478,180, filed Jul. 16, 2019. |
U.S. Appl. No. 62/452,437, filed Jan. 31, 2017. |
U.S. Appl. No. 62/665,297, filed May 1, 2018. |
U.S. Appl. No. 62/665,302, filed May 1, 2018. |
U.S. Appl. No. 62/665,317, filed May 1, 2018. |
U.S. Appl. No. 62/665,321, filed May 1, 2018. |
U.S. Appl. No. 62/665,331, filed May 1, 2018. |
U.S. Appl. No. 62/665,335, filed May 1, 2018. |
U.S. Appl. No. 62/994,912, filed Mar. 26, 2020. |
Defendant and Counterclaim Plaintiff Sage Products, LLC's Answer, Defenses, and Counterclaims to Plaintiff's Amended Complaint, Nov. 1, 2019. |
Parmar, “10 Finalists Chosen for Dare-to-Dream Medtech Design Challenge (PureWick),” Design Services, Nov. 10, 2014 (3 pages). |
Purewick, “Incontinence Relief for Women” Presentation, (7 pages), Sep. 23, 2015. |
Pytlik, “Super Absorbent Polymers,” University of Buffalo http://www.courses.sens.buffalo.edu/ce435/Diapers/Diapers.html, accessed on Feb. 17, 2017. |
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated May 11, 2020. |
Notice of Allowance for U.S. Appl. No. 29/624,661 dated May 14, 2020. |
U.S. Appl. No. 63/011,445, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,487, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,571, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,657, filed Apr. 17, 2020. |
U.S. Appl. No. 63/011,760, filed Apr. 17, 2020. |
U.S. Appl. No. 63/012,347, filed Apr. 20, 2020. |
U.S. Appl. No. 63/012,384, filed Apr. 20, 2020. |
Final Office Action for U.S. Appl. No. 14/952,591 dated Nov. 27, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/023572 dated Jul. 6, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/040860 dated Oct. 2, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/041242 dated Nov. 17, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/041249 dated Oct. 2, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/042262 dated Oct. 14, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/043059 dated Oct. 6, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/044024 dated Nov. 12, 2020. |
International Search Report and Written Opinion from International Application No. PCT/US2020/046914 dated Dec. 1, 2020. |
Non-Final Office Action for U.S. Appl. No. 16/899,956 dated Oct. 16, 2020. |
Non-Final Office Action for U.S. Appl. No. 16/904,868 dated Nov. 25, 2020. |
Non-Final Office Action for U.S. Appl. No. 16/905,400 dated Dec. 2, 2020. |
Non-Final Office Action for U.S. Appl. No. 29/694,002 dated Jun. 24, 2020. |
Notice of Allowance for U.S. Appl. No. 15/171,968 dated Nov. 6, 2020. |
Notice of Allowance for U.S. Appl. No. 29/624,661 dated Jul. 10, 2020. |
Notice of Allowance for U.S. Appl. No. 29/624,661 dated Sep. 29, 2020. |
Notice of Allowance for U.S. Appl. No. 29/694,002 dated Oct. 16, 2020. |
U.S. Appl. No. 15/260,103, filed Sep. 8, 2016. |
U.S. Appl. No. 15/611,587, filed Jun. 1, 2017. |
U.S. Appl. No. 16/904,868, filed Jun. 18, 2020. |
U.S. Appl. No. 16/905,400, filed Jun. 18, 2020. |
U.S. Appl. No. 17/051,550, filed Oct. 29, 2020. |
U.S. Appl. No. 17/051,554, filed Oct. 29, 2020. |
U.S. Appl. No. 17/051,585, filed Oct. 29, 2020. |
U.S. Appl. No. 17/051,600, filed Oct. 29, 2020. |
U.S. Appl. No. 17/088,272, filed Nov. 3, 2020. |
U.S. Appl. No. 29/741,751, filed Jul. 15, 2020. |
U.S. Appl. No. 62/853,889, filed May 29, 2019. |
U.S. Appl. No. 62/873,045, filed Jul. 11, 2019. |
U.S. Appl. No. 62/873,048, filed Jul. 11, 2019. |
U.S. Appl. No. 62/876,500, filed Jul. 19, 2019. |
U.S. Appl. No. 62/889,149, filed Aug. 20, 2019. |
U.S. Appl. No. 63/061,241, filed Aug. 5, 2020. |
U.S. Appl. No. 63/061,244, filed Aug. 5, 2020. |
U.S. Appl. No. 63/061,834, filed Aug. 6, 2020. |
U.S. Appl. No. 63/064,017, filed Aug. 11, 2020. |
U.S. Appl. No. 63/064,126, filed Aug. 11, 2020. |
U.S. Appl. No. 63/071,438, filed Aug. 28, 2020. |
U.S. Appl. No. 63/074,051, filed Sep. 3, 2020. |
U.S. Appl. No. 63/074,066, filed Sep. 3, 2020. |
U.S. Appl. No. 63/076,032, filed Sep. 9, 2020. |
U.S. Appl. No. 63/076,474, filed Sep. 10, 2020. |
U.S. Appl. No. 63/076,477, filed Sep. 10, 2020. |
U.S. Appl. No. 63/082,261, filed Sep. 23, 2020. |
U.S. Appl. No. 63/088,506, filed Oct. 7, 2020. |
U.S. Appl. No. 63/088,511, filed Oct. 7, 2020. |
U.S. Appl. No. 63/094,464, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,594, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,608, filed Oct. 21, 2020. |
U.S. Appl. No. 63/094,626, filed Oct. 21, 2020. |
U.S. Appl. No. 63/109,066, filed Nov. 3, 2020. |
U.S. Appl. No. 63/112,417, filed Nov. 11, 2020. |
U.S. Appl. No. 63/119,161, filed Nov. 30, 2020. |
U.S. Appl. No. 63/094,498, filed Oct. 21, 2020. |
Sage's Initial Invalidity Contentions Regarding U.S. Pat. No. 8,287,508; U.S. Pat. No. 10,226,375; and U.S. Pat. No. 10,390,989, May 29, 2020, 193 pages. |
Sage's Supplemental and Initial Invalidity Contentions Regarding U.S. Pat. No. 8,287,508; U.S. Pat. No. 10,226,375; U.S. Pat. No. 10,390,989 and Initial Invalidity Contentions Regarding U.S. Pat. No. 10,376,407, Aug. 21, 2020, 277 pages. |
Excerpts from the 508 (U.S. Pat. No. 8,278,508) Patent's Prosecution History, 2020, 99 pages. |
Plaintiff's Opening Claim Construction Brief, Case No. 19-1508-MN, Oct. 16, 2020, 26 pages. |
Plaintiff's Identification of Claim Terms and Proposed Constructions, Case No. 19-1508-MN, 3 pages. |
PureWick's Response to Interrogatory No. 9 in PureWick, LLC v. Sage Products, LLC, Case No. 19-1508-MN, Mar. 23, 2020, 6 pages. |
Sage's Preliminary Identification of Claim Elements and Proposed Constructions for U.S. Pat. No. 8,287,508, U.S. Pat. No. 10,226,376, U.S. Pat. No. 10,390,989 and U.S. Pat. No. 10,376,407, Case No. 19-1508-MN, 7 pages. |
Corrected Certificate of Service, Case No. IPR2020-01426, U.S. Pat. No. 8,287,508, 2020, 2 pages. |
Declaration of Diane K. Newman Curriculum Vitae, Petition for Interparties Review, 2020, pp. 1-199. |
“3 Devices Take Top Honors in Dare-To-Dream Medtech Design Contest”, R+D Digest, Nov. 2013, 1 page. |
“Advanced Mission Extender Device (AMDX) Products”, Omni Medical Systems, Inc., 15 pages. |
“AMXDX—Advanced Mission Extender Device Brochure”, Omni Medical, Omni Brochure—http://www.omnimedicalsys.com/uploads/AMXDFixedWing.pdf, 2 pages. |
“External Urine Management for Female Anatomy”, https://www.stryker.com/us/en/sage/products/sage-primafit.html, Jul. 2020, 4 pages. |
“High Absorbancy Cellulose Acetate Electrospun Nanofibers for Feminine Hygiene Application”, https://www.sciencedirect.com/science/article/abs/pii/S2352940716300701?via%3Dihub, Jul. 2016, 3 pages. |
“How Period Panties Work”, www.shethinx.com/pages/thinx-itworks, 2020, 10 pages. |
“Hydrogel properties of electrospun polyvinylpyrrolidone and polyvinylpyrrolidone/poly(acrylic acid) blend nanofibers”, https://pubs.rsc.org/en/content/articlelanding/2015/ra/c5ra07514a#!divAbstract, 2015, 5 pages. |
“In Flight Bladder Relief”, Omni Medical, Omni Presentation https://www.omnimedicalsys.com/uploads/AMXDmax_HSD.pdf, 14 pages. |
“Making Women's Sanitary Products Safer and Cheaper”, https://www.elsevier.com/connect/making-womens-sanitary-products-safer-and-cheaper, Sep. 2016, 10 pages. |
“Novel Nanofibers Make Safe and Effective Absorbent for Sanitary Products”, https://www.materialstoday.com/nanomaterials/news/nanofibers-make-safe-and-effective-absorbent/, Oct. 2016, 3 pages. |
“Research and Development Work Relating to Assistive Technology 2005-06”, British Department of Health, Nov. 2006, 40 pages. |
“Underwear that absorbs your period”, Thinx!, https://www.shethinx.com/pages/thinx-it-works last accessed Jun. 24, 2020, 7 pages. |
Hollister, Female Urinary and Pouch and Male Urinary Pouch Brochure, 2011, 1 page. |
Hollister, “Retracted Penis Pouch by Hollister”, Vitality Medical.com, https://www.vitalitymedical.com/hollister-retracted-penis-pouch.html last accessed Jun. 24, 2020, 6 pages. |
Macaulay, et al., “A Noninvasive Continence Management System: Development and Evaluation of a Novel Toileting Device for Women”, The Wound, Ostomy and Continence Nurses Society, vol. 34 No. 6, 2007, pp. 641-648. |
Newman, et al., “The Urinary Incontinence Sourcebook”, Petition for Interparties Review, 1997, 23 pages. |
Sachtman, Noah, “New Relief for Pilots? It Depends”, Wired, https://www.wired.com/2008/05/pilot-relief/, 2008, 2 pages. |
International Search Report and Written Opinion from International Application No. PCT/US2020/055680 dated Dec. 15, 2020. |
Non-Final Office Action for U.S. Appl. No. 17/088,272 dated Jan. 25, 2021. |
Notice of Allowance for U.S. Appl. No. 29/694,002 dated Jan. 29, 2021. |
U.S. Appl. No. 62/949,187, filed Dec. 17, 2019. |
U.S. Appl. No. 62/956,756, filed Jan. 3, 2020. |
U.S. Appl. No. 62/956,767, filed Jan. 3, 2020. |
U.S. Appl. No. 62/956,770, filed Jan. 3, 2020. |
U.S. Appl. No. 63/134,287, filed Jan. 6, 2021. |
U.S. Appl. No. 63/134,450, filed Jan. 6, 2021. |
U.S. Appl. No. 63/134,631, filed Jan. 7, 2021. |
U.S. Appl. No. 63/134,632, filed Jan. 7, 2021. |
U.S. Appl. No. 63/134,754, filed Jan. 7, 2021. |
Sage's Second Supplemental Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508, 10,226,375, 10,390,989, and 10,376,407, 292 pages. |
“AMXD Control Starter Kit Brochure”, https://www.omnimedicalsys.com/index.php?page=products, Omni Medical, 8 pages. |
“User & Maintenance Guide”, Omni Medical, 2007, 16 pages. |
“Winners Announced for Dare-to-Dream Medtech Design Challenge”, https://www.mddionline.com/design-engineering/winners-announced-dare-dream-medtech-design-challenge, MD&DI, 2014, 4 pages. |
Newton, et al., “Measuring Safety, Effectiveness and Ease of Use of PureWick in the Management of Urinary Incontinence in Bedbound Women: Case Studies”, Jan. 8, 2016, 11 pages. |
Notice of Allowance for U.S. Appl. No. 15/171,968 dated Feb. 16, 2021. |
Notice to File Missing Parts for U.S. Appl. No. 17/179,116 dated Mar. 3, 2021. |
U.S. Appl. No. 63/147,013, filed Feb. 8, 2021. |
U.S. Appl. No. 63/147,299, filed Feb. 9, 2021. |
U.S. Appl. No. 63/148,723, filed Feb. 12, 2021. |
U.S. Appl. No. 63/154,248, filed Feb. 26, 2021. |
U.S. Appl. No. 63/155,395. filed Mar. 2, 2021. |
Decision Granting Institution of Inter Partes Review for U.S. Pat. No. 8,287,508, Case No. 2020-01426, 39 pages, Feb. 17, 2021. |
Number | Date | Country | |
---|---|---|---|
20180028349 A1 | Feb 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15238427 | Aug 2016 | US |
Child | 15612325 | US | |
Parent | 15221106 | Jul 2016 | US |
Child | 15238427 | US |